<SEC-DOCUMENT>0001558370-21-005857.txt : 20210505
<SEC-HEADER>0001558370-21-005857.hdr.sgml : 20210505
<ACCEPTANCE-DATETIME>20210505125415
ACCESSION NUMBER:		0001558370-21-005857
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20210505
FILED AS OF DATE:		20210505
DATE AS OF CHANGE:		20210505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GENMAB A/S
		CENTRAL INDEX KEY:			0001434265
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38976
		FILM NUMBER:		21892225

	BUSINESS ADDRESS:	
		STREET 1:		TOLDBODGADE 33
		CITY:			1253 COPENHAGEN K
		STATE:			G7
		ZIP:			00000

	MAIL ADDRESS:	
		STREET 1:		TOLDBODGADE 33
		CITY:			1253 COPENHAGEN K
		STATE:			G7
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tmb-20210505x6k.htm
<DESCRIPTION>6-K
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.10.0.88--><!--Created on: 5/5/2021 04:54:05 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:6pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Washington,&#160;D.C. 20549</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;"><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br></b><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">FORM&#160;6-K</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE&#160;13a-16 OR&#160;15d-16</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">FOR THE&#160;MONTH OF MAY 2021</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;white-space:pre-wrap;">COMMISSION FILE NUMBER 001-38976  </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">Genmab A/S<br></b><font style="background-color:#ffffff;color:#333333;font-family:'Arial','Helvetica','sans-serif';font-size:9.5pt;">(Exact name of Registrant as specified in its charter)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Kalvebod Brygge 43</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">1560 Copenhagen V</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Denmark</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;">+45 70 20 27 28<br></b><font style="background-color:#ffffff;color:#333333;font-family:'Arial','Helvetica','sans-serif';font-size:9.5pt;">(Address of principal executive offices)</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F or&#160;Form&#160;40-F.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;">Form&#160;20-F&#160;</font><font style="font-family:'Times New Roman';">&#8999;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">      Form&#160;40-F&#160;</font><font style="font-family:'Times New Roman';font-size:10pt;">&#9723;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Indicate by check mark if the registrant is submitting the Form&#160;6-K in paper as permitted by Regulation&#160;S-T Rule&#160;101(b)(1)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;">Yes&#160;</font><font style="font-family:'Times New Roman';font-size:10pt;">&#9723;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">      No&#160;</font><font style="font-family:'Times New Roman';">&#8999;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">  </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Indicate by check mark if the registrant is submitting the Form&#160;6-K in paper as permitted by Regulation&#160;S-T Rule&#160;101(b)(7)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;">Yes&#160;</font><font style="font-family:'Times New Roman';font-size:10pt;">&#9723;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">      No&#160;</font><font style="font-family:'Times New Roman';">&#8999;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">  </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="background-color:#ffffff;">Exhibit 99.1 to this report on Form&#160;6-K&#160;shall be deemed to be&#160;</font>incorporated by reference<font style="background-color:#ffffff;">&#160;in Genmab A/S&#8217;s registration statement on&#160;</font><font style="background-color:#ffffff;">Form&#160;S-8</font><font style="background-color:#ffffff;">&#160;(File&#160;No.&#160;333-232693)&#160;and in the outstanding prospectus contained in such registration statement. </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:6pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">SIGNATURE</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">GENMAB A/S</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">BY:</font></p></td><td style="vertical-align:bottom;width:45.3%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">/s/ Anthony Pagano</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:45.3%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Name: Anthony Pagano</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Title: Executive Vice President &amp; Chief Financial Officer</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">DATE: May 5, 2021</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">EXHIBIT&#160;INDEX</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;table-layout:auto;width:96.42%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">A</b></p></div></div></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><u style="font-family:'Arial','Helvetica','sans-serif';text-decoration:underline;text-decoration-color:#000000;">Exhibit</u></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><u style="font-family:'Arial','Helvetica','sans-serif';text-decoration:underline;text-decoration-color:#000000;">Description of Exhibit</u></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">99.1</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';white-space:pre-wrap;">Interim Report Dated May 5, 2021    &#160;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tmb-20210505xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.10.0.88--><!--Created on: 5/5/2021 04:54:02 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title>Interim Report for the 6 months ended June 30, 2011</title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Genmab Announces Financial Results for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;">May 5, 2021; Copenhagen, Denmark; </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Genmab Interim Report for the First Quarter Ended March 31, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Highlights</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Genmab and Seagen Inc. submitted tisotumab vedotin Biologics License Application (BLA) to the U.S. FDA for patients with recurrent or metastatic cervical cancer</b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">First patient dosed in Phase 3 epcoritamab study triggers USD 40 million milestone in collaboration with AbbVie Inc. </b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">DARZALEX</b><sup style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:bold;text-align:left;vertical-align:top;">&#174;</sup><b style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;"> net sales increased 46% compared to the first quarter of 2020 to USD 1,365 million, resulting in royalty income of DKK 984 million </b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Janssen Biotech, Inc. granted U.S. FDA approval for DARZALEX </b><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:left;">FASPRO</font><sup style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:bold;text-align:left;vertical-align:top;">&#174;</sup><b style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;"> (daratumumab and hyaluronidase-fihj) for patients with newly diagnosed light-chain (AL) amyloidosis</b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Novartis received a positive CHMP opinion, followed by approval in Europe, for Kesimpta</b><sup style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:bold;text-align:left;vertical-align:top;">&#174;</sup><b style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;"> (ofatumumab) in the treatment of relapsing forms of multiple sclerosis</b><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> </font><b style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">in adults with active disease defined by clinical or imaging features</b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Tahamtan Ahmadi appointed Executive Vice President and Chief Medical Officer, Head of Experimental Medicines</b></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk12956096"></a>&#8220;In 2020, Genmab reached an inflection point in our evolution into a fully integrated biotech innovation powerhouse. This momentum has continued into the first quarter of 2021, with the BLA submission for tisotumab vedotin, our product in development with Seagen. If approved by the U.S. FDA, we believe that tisotumab vedotin as monotherapy has the potential to become an important treatment option for women with recurrent or metastatic cervical cancer, who have disease progression on or after chemotherapy,&#8221; said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Financial Performance First Quarter of 2021</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Revenue was DKK 1,581 million in the first quarter of 2021 compared to DKK 892 million in the first quarter of 2020. </font><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"><a name="_Hlk527456255"></a></font><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">The increase of DKK 689 million, or 77%, was primarily driven by higher DARZALEX royalties and milestones related to epcoritamab and DARZALEX </font><i style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;text-align:left;">FASPRO</i><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Net sales of DARZALEX by Janssen Biotech Inc. (Janssen) were USD 1,365 million in the first quarter of 2021 compared to USD 937 million in the first quarter of 2020, an increase of USD 428 million, or 46%.</font><font style="background-color:#ffff00;color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"><a name="_Hlk527456303"></a></font><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Operating expenses were DKK 1,049 million in the first quarter of 2021 compared to DKK 821 million in the first quarter of 2020. The increase of DKK 228 million, or 28%, was driven by the continued advancement of multiple pipeline projects, and the increase in new employees to support the expansion of our product pipeline and building our commercialization capabilities and infrastructure.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"><a name="OLE_LINK13"></a><a name="OLE_LINK14"></a></font><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Operating result was DKK 532 million in the first quarter of 2021 compared to DKK 71 million in the first quarter of 2020. The increase of DKK 461 million was driven by higher revenue, which was partly offset by increased operating expenses.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Outlook</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab is maintaining its 2021 financial guidance published on February 23, 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Conference Call</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab will hold a conference call in English to discuss the results for the first quarter of 2021 today, Wednesday, May 5, at 6:00 pm CEST, 5:00 pm BST or 12:00 pm EDT. To join the call dial </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 1/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Genmab Announces Financial Results for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="OLE_LINK3"></a><a name="OLE_LINK4"></a>+1 631 913 1422 (U.S. participants) or +44 3333 000804 (international participants) and provide conference code 29164332.<br><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">A live and archived webcast of the call and relevant slides will be available at <font style="color:#029c93;">www.genmab.com/investors</font>.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Contact:</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Marisol Peron, Senior Vice President, Global Investor Relations and Communications </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">T: +1 609 524 0065; E: <font style="color:#029c93;">mmp@genmab.com</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">For Investor Relations: </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Andrew Carlsen, Vice President, Head of Investor Relations</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">T: +45 3377 9558; E: <font style="color:#029c93;">acn@genmab.com</font><font style="white-space:pre-wrap;">  </font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 2/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">CONTENTS</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">MANAGEMENT&#8217;S REVIEW</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:99.03%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt;"><font style="line-height:1.06;"><a name="_Toc16514640"></a></font><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#CONSOLIDATEDKEYFIGURES_439617"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">CONSOLIDATED KEY FIGURES</font></a></p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">4</p></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#OUTLOOK_182548"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">OUTLOOK</font></a></p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">5</p></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#KEY2019PRIORITIES_328557"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">KEY 2021 PRIORITIES</font></a></p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">6</p></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#PRODUCTPIPELINE_603298"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">PRODUCT PIPELINE</font></a> <a href="#PRODUCTPIPELINE_603298"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">AND TECHNOLOGY PROGRESS FIRST QUARTER OF 2021</font></a></p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">6</p></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#_SIGNIFICANT_RISKS_AND"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">SIGNIFICANT RISKS AND UNCERTAINTIES</font></a></p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">14</p></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#FINANCIALREVIEW_601130"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">FINANCIAL REVIEW</font></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">FINANCIAL STATEMENTS</b></p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">15</p></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#STATEMENTOFCOMPREHENSIVEINCOMEFORTHE3RDQ"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">STATEMENT OF COMPREHENSIVE INCOME FOR THE FIRST QUARTER OF 2021</font></a></p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">20</p></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#BALANCESHEET_757698"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">BALANCE SHEET AS OF MARCH 31, 2021</font></a> </p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">21</p></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#STATEMENTOFCASHFLOWS_489627"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">STATEMENT OF CASH FLOWS AS OF MARCH 31, 2021</font></a> </p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">22</p></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#STATEMENTOFCHANGESINEQUITY_43137"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">STATEMENT OF CHANGES IN EQUITY AS OF MARCH 31, 2021</font></a> </p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">23</p></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#NOTESTOTHEFINANCIALSTATEMENTS_435403"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">NOTES&#160;TO THE FINANCIAL STATEMENTS</font></a></p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">24</p></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="color:#029c93;" href="#ABOUTGENMAB_556806"><b style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">ABOUT GENMAB</b></a></p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">33</p></td></tr><tr><td style="vertical-align:top;width:96.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="color:#029c93;" href="#DIRECTORSANDMANAGEMENTSSTATEMENTONTHEINT"><b style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">DIRECTORS&#8217; AND MANAGEMENT&#8217;S STATEMENT ON THE INTERIM REPORT</b></a></p></td><td style="vertical-align:top;width:3.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">34</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 3/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="color:#029c93;font-weight:bold;">CONSOLIDATED KEY FIGURES</b><b style="font-size:16pt;font-weight:bold;"><a name="_MON_1428392831"></a></b><b style="color:#339966;font-weight:bold;white-space:pre-wrap;">   </b><b style="font-size:16pt;font-weight:bold;"><a name="CONSOLIDATEDKEYFIGURES_439617"></a></b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">1st Quarter of</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">1st Quarter of</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;&#160;</p></td><td colspan="2" style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">Full Year</p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">2021</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">2020</p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Income Statement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,581</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 892</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,111</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (848)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (715)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,137)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">General and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (201)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (106)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (661)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,049)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (821)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,798)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Operating result</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 532</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 71</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,313</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Net financial items</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 892</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 283</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (409)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Net result</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,096</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 269</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,758</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Balance Sheet</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash position*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 18,083</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 12,960</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16,079</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Total non-current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,273</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,213</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,352</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Total assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 22,210</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15,303</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 21,143</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Shareholders&#39; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20,095</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 14,398</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 19,121</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Share capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Cash Flow Statement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash flow from operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,185</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,914</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,433</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash flow from investing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (579)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,351)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash flow from financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (220)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 71</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,892</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,543</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,260</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash position increase/(decrease)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,004</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,989</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,108</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Investment in tangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (28)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (58)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (307)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Financial Ratios</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Basic net result per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16.76</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4.13</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 73.00</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Diluted net result per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16.61</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4.09</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 72.21</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Period-end share market price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,087.00</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,377.00</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,463.00</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Price / book value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6.85</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6.22</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.50</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Shareholders&#39; equity per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 304.47</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 221.51</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 289.71</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Equity ratio</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 90</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 94</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 90</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Average number of employees (FTE**)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 842</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 569</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 656</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:42.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Number of employees at the end of the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 871</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 579</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 781</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:2.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">* Cash, cash equivalents, and marketable securities. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">** Full-time equivalent</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 4/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;font-weight:bold;text-indent:0pt;margin:12pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514641"></a></b><b style="color:#029c93;font-size:11pt;font-weight:bold;">OUTLOOK</b><b style="color:#029c93;font-size:11pt;font-weight:bold;"> </b><b style="font-size:16pt;font-weight:bold;"><a name="OUTLOOK_182548"></a><a name="_Hlk22722517"></a></b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:22.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:69.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Guidance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">6,800 - 7,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(5,500) - (5,800)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:69.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating result</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">1,000 - 2,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab is maintaining its 2021 financial guidance published on February 23, 2021. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">We expect our 2021 revenue to be in the range of DKK 6,800&#8211;7,500 million, compared to DKK 10,111 million in 2020. Our revenue in 2020 was significantly impacted by the AbbVie Inc. (AbbVie) collaboration and included DKK 4,398 million related to the portion of the upfront payment that was allocated to the license grants and recognized as revenue in 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Our projected revenue for 2021 primarily consists of DARZALEX royalties of DKK 4,900&#8211;5,300 million. Such royalties are based on estimated DARZALEX 2021 net sales of USD 5.2&#8211;5.6 billion compared to actual net sales in 2020 of USD 4.2 billion. Since the second quarter of 2020, Janssen has reduced its royalty payments to Genmab by what it claims to be Genmab&#8217;s share of Janssen&#8217;s royalty payments to Halozyme in connection with subcutaneous sales. Given the ongoing arbitration, Genmab has reflected this as a reduction to estimated 2021 revenue. The remainder of our revenue consists of royalties from TEPEZZA<sup style="font-size:7.5pt;vertical-align:top;">&#174;</sup> and Kesimpta, reimbursement revenue, milestones for epcoritamab and daratumumab, and other milestones.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Operating Expenses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">We anticipate our 2021 operating expenses to be in the range of DKK 5,500&#8211;5,800 million, compared to DKK 3,798 million in 2020. The increase is driven by the advancement of our clinical programs, continued investment in research and development, as well as building our commercial organization and infrastructure.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Operating Result</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">We expect our operating result to be in the range of DKK 1,000&#8211;2,000 million in 2021, compared to DKK 6,313 million in 2020.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Outlook: Risks and Assumptions</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In addition to factors already mentioned, the estimates above are subject to change due to numerous reasons, including but not limited to the achievement of certain milestones associated with our collaboration agreements; our ongoing binding arbitration of two matters under our license agreement with Janssen relating to daratumumab; the timing and variation of development activities (including activities carried out by our collaboration partners) and related income and costs; DARZALEX, Kesimpta and TEPEZZA<sup style="font-size:7.5pt;vertical-align:top;"> </sup>net sales and royalties paid to Genmab; and currency exchange rates (the 2021 guidance assumes a USD/DKK exchange rate of 6.0). In December 2020, Horizon Therapeutics announced that there was a supply disruption related to the production of TEPEZZA due to U.S. government-mandated COVID-19 vaccine production requirements. Subsequently, in March 2021, Horizon Therapeutics announced its plans to resupply the market beginning in April 2021. The financial guidance assumes that no significant new agreements are entered into during the remainder of 2021 that could materially affect the results. Refer to the section &#8220;Significant Risks and Uncertainties&#8221; in this interim report. Additionally, the COVID-19 pandemic could potentially have a material adverse impact on our business and financial performance, including our clinical trials, projected regulatory approval timelines, supply chain and </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 5/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">revenues, and cause our actual results to differ materially from our 2021 Guidance and Key 2021 Priorities in this interim report. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The global outbreak of COVID-19 may have long-term impacts on the development, regulatory approval and commercialization of our product candidates and on net sales of approved products created by Genmab and developed and marketed by our collaboration partners. The longer the pandemic continues, the more severe the impacts described below will be on our business. The extent, length and consequences of the pandemic are uncertain and impossible to predict. Genmab has established a COVID-19 response team, led by the CEO, that closely monitors the evolving situation, develops and implements precautionary measures to help limit the impact of COVID-19 at our workplace and on our communities, and ensures business continuity. Genmab is also actively monitoring the potential impact on our Key 2021 Priorities and assessing the situation on an ongoing basis in close contact with clinical trial sites, physicians and contract research organizations (CROs) to evaluate the impact and challenges posed by the COVID-19 situation and manage them accordingly. The full extent and nature of the impact of the COVID-19 pandemic and related containment measures on our business and financial performance is uncertain as the situation continues to evolve. The factors discussed above, as well as other factors which are currently unforeseeable, may result in further and other unforeseen material adverse impacts on our business and financial performance, including on the net sales of DARZALEX, Kesimpta and TEPEZZA, by our partners and on our royalty and milestone revenue therefrom.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:12pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514642"></a></b><b style="color:#029c93;font-weight:bold;">KEY 2021 PRIORITIES</b><b style="font-size:16pt;font-weight:bold;"><a name="KEY2019PRIORITIES_328557"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:23.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><b style="color:#029c93;font-weight:bold;">Priority</b></p></td><td style="vertical-align:top;width:6.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><b style="color:#029c93;font-family:'Segoe UI Emoji';font-weight:bold;">&#10004;</b></p></td><td colspan="2" style="vertical-align:top;width:69.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><b style="color:#029c93;font-weight:bold;">Targeted Milestones</b></p></td></tr><tr><td style="vertical-align:top;width:23.16%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><b style="color:#029c93;font-weight:bold;">Bring our own medicines to patients</b></p></td><td style="vertical-align:top;width:6.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.93%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="vertical-align:top;width:66.95%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;">Tisotumab vedotin<sup style="font-size:7.5pt;vertical-align:top;">1</sup> &#8211; U.S. FDA decision on BLA and progress to market</p></td></tr><tr><td style="vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;">*</p></td><td style="vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;">Tisotumab vedotin &#8211; JNDA submission in cervical cancer</p></td></tr><tr><td style="vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Epcoritamab<sup style="font-size:7.5pt;vertical-align:top;">2</sup> &#8211; acceleration and maximization of development program by advancing expansion cohorts and initiating additional Phase 3 trials</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td rowspan="4" style="background-color:#e5e5e6;vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><b style="color:#029c93;font-weight:bold;">Build world-class differentiated product </b></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"></td><td style="background-color:#e5e5e6;vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;">DuoBody-PD-L1x4-1BB<sup style="font-size:7.5pt;vertical-align:top;">3 </sup>&#8211; expansion cohort data</p></td></tr><tr><td style="background-color:#e5e5e6;display:none;vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;">DuoBody-CD40x4-1BB<sup style="font-size:7.5pt;vertical-align:top;">3</sup> &#8211; dose escalation data</p></td></tr><tr><td style="background-color:#e5e5e6;display:none;vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Tisotumab vedotin &#8211; data in other tumor indication</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="background-color:#e5e5e6;display:none;vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Earlier-stage products &#8211; progress and expand innovative product pipeline</p></td></tr><tr><td rowspan="2" style="vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><b style="color:#029c93;font-weight:bold;">Become leading integrated innovation powerhouse</b></p></td><td style="vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;">Operational commercialization model in U.S. and Japan</p></td></tr><tr><td style="display:none;vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><font style="color:#029c93;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="color:#029c93;font-family:'Segoe UI Emoji';font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Further strengthen solid financial foundation </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1.&#160;Co-development w/ Seagen Inc. (Seagen); 2. Co-development w/ AbbVie; 3. Co-development w/ BioNTech</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">*Potential JNDA filing timeline postponed to include Phase 3 InnovaTV301 data</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Toc16514643"></a><b style="color:#029c93;font-weight:bold;">PRODUCT PIPELINE</b><a name="PRODUCTPIPELINE_603298"></a><b style="color:#029c93;font-weight:bold;"> AND TECHNOLOGY PROGRESS FIRST QUARTER OF 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of the end of the first quarter, Genmab&#8217;s proprietary pipeline of product candidates, where we are responsible for at least 50% of development, consisted of eight clinical stage antibodies. In addition to our own pipeline, there are also 15 products in development by third-party companies, including three approved products, which incorporate Genmab technology and innovation. Beyond the antibodies in clinical development, our pipeline also includes around twenty in-house and partnered pre-clinical programs. An overview of the development status of each of our products is provided in the following </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 6/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">sections. Detailed descriptions of dosing, efficacy and safety data from certain clinical trials have been disclosed in company announcements and media releases published via the Nasdaq Copenhagen stock exchange and may also be found in Genmab&#8217;s filings with the U.S. Securities and Exchange Commission (SEC). Additional information is available on Genmab&#8217;s website, <font style="color:#029c93;">www.genmab.com</font>. The information accessible through our website is not part of and is not incorporated by reference herein.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="PRODUCTPIPELINEANDTECHNOLOGYPROGRESSFIRS"></a><font style="color:#339966;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Approved Medicines Created by Genmab</b><sup style="color:#029c93;font-size:8.25pt;font-weight:bold;vertical-align:top;">1</sup></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="color:#029c93;font-weight:bold;"><img src="tmb-20210505xex99d1005.jpg" alt="Graphical user interface, application, table&#10;&#10;Description automatically generated" style="display:inline-block;height:189.35pt;width:468pt;"></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><sup style="font-size:6pt;vertical-align:top;">1</sup>Products developed and marketed by others incorporating Genmab technology and innovation</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;min-height:11.0pt;margin:0pt;"><sup style="font-size:6pt;vertical-align:top;">2</sup>See local country prescribing information for precise indications</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt;"><font style="font-size:8pt;margin-bottom:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DARZALEX (daratumumab) </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">&#8211; Redefining the Treatment of Multiple Myeloma</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">First-in-class human CD38 monoclonal antibody</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed by Janssen under an exclusive worldwide license from Genmab to develop, manufacture and commercialize daratumumab </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Intravenous (IV) formulation approved in combination with other therapies for frontline and for relapsed/refractory multiple myeloma in territories including the U.S., Europe and Japan and as monotherapy for heavily pretreated or double-refractory multiple myeloma in territories including the U.S. and Europe</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">First and only subcutaneous (SubQ) CD38-directed antibody approved in territories including the U.S., Europe and Japan for the treatment of certain multiple myeloma indications, known as DARZALEX </font><i style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;text-align:left;">FASPRO</i><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> (daratumumab and hyaluronidase-fihj) in the U.S.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">DARZALEX </font><i style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;text-align:left;">FASPRO</i><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> - First and only U.S. Food and Drug Administration (U.S. FDA) approved therapy for AL amyloidosis. DARZALEX</font><i style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;text-align:left;"> FASPRO</i><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> milestone of USD 30 million achieved during the first quarter of 2021 driven by the first commercial sale in the U.S. for patients with newly diagnosed AL amyloidosis.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Net sales of DARZALEX by Janssen were USD 1,365 million in the first quarter of 2021</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DARZALEX (daratumumab) is a human monoclonal antibody that binds with high affinity to the CD38 molecule, which is highly expressed on the surface of multiple myeloma cells and is also expressed by AL amyloidosis plasma cells. Daratumumab triggers a person&#8217;s own immune system to attack the cancer cells, resulting in rapid tumor cell death through multiple immune-mediated mechanisms of action and </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 7/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">through immunomodulatory effects, in addition to direct tumor cell death, via apoptosis (programmed cell death). Genmab used technology licensed from Medarex to generate the CD38 antibody forming part of daratumumab. Daratumumab is being developed by Janssen under an exclusive worldwide license from Genmab to develop, manufacture and commercialize daratumumab. Daratumumab (marketed as DARZALEX for intravenous administration and as DARZALEX <i style="font-style:italic;">FASPRO </i>in the United States and as DARZALEX SC in Europe for subcutaneous administration) is approved in certain territories for the treatment of adult patients with certain multiple myeloma indications. DARZALEX <i style="font-style:italic;">FASPRO </i>is also approved in the United States for the treatment of adult patients with AL amyloidosis.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Please consult the full <font style="color:#029c93;">U.S. Prescribing Information</font> and the full <font style="color:#029c93;">European Summary of Product Characteristics</font><font style="color:#0070c0;"> </font>for DARZALEX (daratumumab) and the full <font style="color:#029c93;">U.S. Prescribing Information for DARZALEX </font><i style="color:#029c93;font-style:italic;">FASPRO</i><font style="color:#0070c0;text-decoration:none;"> </font>(daratumumab and hyaluronidase-fihj)<b style="font-weight:bold;"> </b>for all the labeled safety information.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Quarter 2021 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">January: Janssen was granted U.S. Food and Drug Administration (U.S. FDA) approval for the use of DARZALEX </font><i style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;text-align:left;">FASPRO</i><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> (daratumumab and hyaluronidase-fihj) in combination with bortezomib, cyclophosphamide, and dexamethasone (VCd) for the treatment of adult patients with newly diagnosed AL amyloidosis. The approval was based on data from the Phase 3 ANDROMEDA study (AMY3001 (NCT03201965)).</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Kesimpta (ofatumumab) &#8211; Approved in RMS in the U.S. </b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Human CD20 monoclonal antibody developed by Novartis under a license agreement with Genmab</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Approved in the U.S. and Europe for treatment of relapsing forms of multiple sclerosis (RMS) in adults</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">First B-cell therapy that can be self-administered by patients at home using the Sensoready</font><sup style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;text-align:left;vertical-align:top;">&#174;</sup><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> autoinjector pen</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Ofatumumab is a human monoclonal antibody that targets an epitope on the CD20 molecule encompassing parts of the small and large extracellular loops. Genmab used technology licensed from Medarex to generate the CD20 antibody forming part of ofatumumab. A SubQ formulation of ofatumumab was investigated in two Phase 3 ASCLEPIOS clinical studies in RMS. The studies compared the efficacy and safety of SubQ ofatumumab versus teriflunomide in patients with RMS and were comprised of approximately 900 patients each. Based on these studies, Kesimpta (ofatumumab) was approved by the U.S. FDA in August 2020 and the European Commission (EC) in March 2021 for the treatment of RMS in adults. Kesimpta is the first B-cell therapy that can be self-administered by patients at home using the Sensoready autoinjector pen, once monthly after starting therapy. Additional studies with RMS patients are ongoing. Ofatumumab in RMS is being developed and marketed worldwide by Novartis under a license agreement between Genmab and Novartis Pharma AG. Under the terms of the agreement, Genmab is entitled to 10% royalties on net sales of Kesimpta.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Please consult the full <font style="color:#029c93;">U.S. Prescribing Information</font> and the full <font style="color:#029c93;">European Summary of Product Characteristics</font> for all the labeled safety information for Kesimpta. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Quarter 2021 Updates</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">March: The EC granted Novartis marketing authorization for the use of Kesimpta (ofatumumab) in the treatment of RMS in adults with active disease defined by clinical or imaging features. This was preceded in January 2021 by a positive opinion from the Committee for Medicinal Products </font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 8/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">for Human Use (CHMP) of the European Medicines Agency (EMA) recommending marketing authorization in the same indication.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">TEPEZZA (teprotumumab-trbw) &#8211; First U.S. FDA-approved medicine for the treatment of thyroid eye disease</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed and commercialized by Horizon Therapeutics, plc (Horizon) for thyroid eye disease (TED)</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">First and only U.S. FDA-approved medicine for the treatment of TED</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Also being explored in diffuse cutaneous systemic sclerosis (dcSSC)</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Teprotumumab, approved by the U.S. FDA in January 2020 under the trade name TEPEZZA, is a human monoclonal antibody that targets the Insulin-like Growth Factor 1 Receptor (IGF-1R), a well-validated target. Genmab used technology licensed from Medarex to generate the IGF-1R antibody forming part of teprotumumab. TEPEZZA is being developed and is commercialized by Horizon. The antibody was created by Genmab under a collaboration with Roche and development and commercialization of the product is now being conducted by Horizon under a license from Roche. Under the terms of Genmab&#8217;s agreement with Roche, Genmab will receive mid-single digit royalties on sales of TEPEZZA. In December 2020, Horizon Therapeutics announced that there was a supply disruption related to the production of TEPEZZA due to U.S. government-mandated COVID-19 vaccine production requirements. Subsequently, in March 2021, Horizon Therapeutics announced its plans to resupply the market beginning in April 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Please consult the full <font style="color:#029c93;">U.S. Prescribing Information</font> for all the labeled safety information for TEPEZZA.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Genmab Proprietary Products</b><sup style="color:#029c93;font-size:8.25pt;font-weight:bold;vertical-align:top;">1 </sup><b style="color:#029c93;font-size:11pt;font-weight:bold;">in Development</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="color:#029c93;font-weight:bold;"><img src="tmb-20210505xex99d1006.jpg" alt="Graphic" style="display:inline-block;height:235.35pt;left:0%;padding-bottom:0.15pt;position:relative;top:0pt;width:468pt;"></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><sup style="font-size:6pt;vertical-align:top;">1</sup>Product candidates where Genmab has &#8805;50% ownership. Certain products in co-development, partners as indicated</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><sup style="font-size:6pt;vertical-align:top;">2</sup>Genmab is developing HexaBody-CD38 in an exclusive worldwide license and option agreement with Janssen </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 9/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Tisotumab vedotin &#8211; A Next Generation Therapeutic</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">An investigational antibody-drug conjugate (ADC) directed to tissue factor (TF), a protein highly prevalent in solid tumors, including cervical cancer, and is associated with poor prognosis</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">The results of the innovaTV 204 Phase 2 single-arm clinical trial evaluating tisotumab vedotin as monotherapy in patients with previously treated recurrent or metastatic cervical cancer was presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Based on this data, a BLA was submitted to the U.S. FDA</font><font style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">; </font><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">potential Japanese New Drug Application (JNDA) filing timeline postponed to include Phase 3 innovaTV 301 data </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Phase 3 study in recurrent or metastatic cervical cancer and multiple</font><font style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> </font><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Phase 2 clinical studies in other solid tumors ongoing</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in collaboration with Seagen</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;"><font style="white-space:pre-wrap;">Tisotumab vedotin is an ADC targeted to TF, a protein involved in tumor signaling and angiogenesis. It is composed of Genmab&#8217;s fully human monoclonal antibody specific for tissue factor and Seagen&#8217;s ADC technology that utilizes a protease-cleavable linker that covalently attaches the microtubule-disrupting agent monomethyl auristatin E (MMAE) to the antibody and releases it upon internalization, inducing target cell death.  Based on its high expression on many solid tumors and its rapid internalization, TF is&#160;a suitable target for an ADC approach. Genmab used technology licensed from Medarex to generate the TF antibody forming part of tisotumab vedotin. Tisotumab vedotin is in clinical development for solid tumors. Tisotumab vedotin is being co-developed by Genmab and Seagen, under an agreement in which the companies share all costs and profits for the product on a 50:50 basis. </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Quarter 2021 Updates</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">February: Genmab and Seagen submitted a BLA to the U.S. FDA seeking accelerated approval for tisotumab vedotin for patients with recurrent or metastatic cervical cancer with disease progression on or after first line standard of care.</font><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> </font><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">The submission is based on the results of the innovaTV 204 Phase 2 single-arm clinical trial evaluating tisotumab vedotin as monotherapy in this setting.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">January: A Phase 3 study of tisotumab vedotin versus chemotherapy in recurrent or metastatic cervical cancer (innovaTV 301 (NCT04697628)) was announced. </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Epcoritamab (DuoBody-CD3xCD20) &#8211; Potential Best-in-class Product Candidate</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Proprietary bispecific antibody created with Genmab&#8217;s DuoBody</font><sup style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;text-align:left;vertical-align:top;">&#174;</sup><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Multiple ongoing clinical studies including a Phase 3 study in relapsed / refractory diffuse large B-cell lymphoma (DLBCL)</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in collaboration with AbbVie</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="background-color:#ffffff;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Epcoritamab is a proprietary bispecific antibody created using Genmab&#8217;s DuoBody technology. Epcoritamab targets CD3, which is expressed on T-cells, and CD20, a clinically well-validated target on malignant B-cells. Genmab used technology licensed from Medarex to generate the CD20 antibody forming part of epcoritamab. Epcoritamab is being co-developed by Genmab and AbbVie. The first Phase 3 clinical study of epcoritamab in relapsed / refractory DLBCL is ongoing. In addition, Phase 1/2 clinical studies in B-cell non-Hodgkin lymphoma (B-NHL) including chronic lymphocytic leukemia (CLL) and in combination with standard of care therapies for B-NHL are ongoing.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Quarter 2021 Updates</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">February: &#8220;Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment&#8221; published in </font><i style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;text-align:left;">Blood Cancer Journal</i><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">.</font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 10/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">January: The first patient was dosed in the Phase 3 study of SubQ epcoritamab versus investigator&#8217;s choice of chemotherapy in patients with relapsed or refractory DLBCL. This triggered a DKK 245 million (USD 40 million) milestone to Genmab under the collaboration with AbbVie.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DuoBody-PD-L1x4-1BB (GEN1046) &#8211; Bispecific Next Generation Checkpoint Immunotherapy</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Bispecific antibody created with Genmab&#8217;s DuoBody technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Phase 1/2 clinical trial in solid tumors ongoing</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in collaboration with BioNTech</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DuoBody-PD-L1x4-1BB (GEN1046) is a proprietary bispecific antibody, jointly owned by Genmab and BioNTech, created using Genmab&#8217;s DuoBody technology. It is being co-developed by Genmab and BioNTech under an agreement in which the companies share all costs and profits for the product on a 50:50 basis. DuoBody-PD-L1x4-1BB targets PD-L1 and 4-1BB, selected to block inhibitory PD 1 / PD-L1 axis and simultaneously conditionally activate essential co-stimulatory activity via 4-1BB using inert DuoBody antibody format. A Phase 1/2 clinical study of DuoBody-PD-L1x4-1BB in solid tumors is ongoing.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DuoBody-CD40x4-1BB (GEN1042) &#8211; Potential First-in-Class Bispecific Agonistic Antibody</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Bispecific antibody created with Genmab&#8217;s DuoBody technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Phase 1/2 clinical trial in solid tumors ongoing </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in collaboration with BioNTech</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DuoBody-CD40x4-1BB (GEN1042) is a proprietary bispecific antibody, jointly owned by Genmab and BioNTech, created using Genmab&#8217;s DuoBody technology. It is being co-developed by Genmab and BioNTech under an agreement in which the companies share all costs and profits for the product on a 50:50 basis. CD40 and 4-1BB were selected as targets to enhance both dendritic cells (DC) and antigen-dependent T-cell activation, using an inert DuoBody format. A Phase 1/2 clinical study (NCT04083599) of DuoBody-CD40x4-1BB in solid tumors is ongoing.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="OLE_LINK15"></a><a name="OLE_LINK16"></a><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">HexaBody-DR5/DR5 (GEN1029) &#8211; First HexaBody</b><sup style="color:#029c93;font-size:7.5pt;font-weight:bold;vertical-align:top;">&#174;</sup><b style="color:#029c93;font-weight:bold;"> Program in Clinical Development</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Proprietary antibody therapeutic created with Genmab&#8217;s HexaBody technology</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Composed of two non-competing HexaBody antibody molecules that target two distinct DR5 epitopes</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Phase 1/2 clinical trial in solid tumors ongoing</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="background-color:#ffffff;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">HexaBody-DR5/DR5 (GEN1029) is a product comprising a mixture of two non-competing HexaBody molecules that target two distinct epitopes on death receptor 5 (DR5), a cell surface receptor that mediates a process called programmed cell death. Increased expression of DR5 has been reported in several types of tumors. The product was created with our HexaBody technology and DR5 antibodies acquired from IDD Biotech. HexaBody-DR5/DR5 is fully owned by Genmab and a Phase 1/2 clinical trial in solid tumors is ongoing.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DuoHexaBody-CD37 (GEN3009) &#8211; First DuoHexaBody</b><sup style="color:#029c93;font-size:7.5pt;font-weight:bold;vertical-align:top;">&#174;</sup><b style="color:#029c93;font-weight:bold;"> Program in the Clinic</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Antibody product created with Genmab&#8217;s DuoHexaBody technology</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Phase 1/2 clinical study in hematologic malignancies ongoing </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in collaboration with AbbVie</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 11/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DuoHexaBody-CD37 (GEN3009) is a bispecific antibody created with Genmab&#8217;s proprietary DuoHexaBody technology platform. The DuoHexaBody platform combines the dual targeting of our DuoBody technology with the enhanced potency of our HexaBody technology, creating bispecific antibodies with target-mediated enhanced hexamerization. DuoHexaBody-CD37 is being co-developed by Genmab and AbbVie on a 50:50 basis and a Phase 1/2 clinical trial in hematologic malignancies is ongoing. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DuoBody-CD3x5T4 (GEN1044) &#8211; Promising Novel Product Candidate</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Bispecific antibody product created with Genmab&#8217;s DuoBody technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Phase 1/2 clinical study in malignant solid tumors ongoing </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in collaboration with AbbVie</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DuoBody-CD3x5T4 (GEN1044) is a bispecific antibody created with Genmab&#8217;s proprietary DuoBody technology platform. DuoBody-CD3x5T4 induces T-cell mediated cytotoxicity of 5T4-positive cells by crosslinking CD3 on T cells with the tumor-associated antigen 5T4 on tumor cells. The broad expression of 5T4 across solid tumors and limited expression in normal cells makes DuoBody-CD3x5T4 a promising novel product candidate. DuoBody-CD3x5T4 is being co-developed by Genmab and AbbVie on a 50:50 basis and a Phase 1/2 clinical trial in malignant solid tumors is ongoing. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">HexaBody-CD38 (GEN3014) &#8211; Latest Proprietary Program in the Clinic</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Proprietary antibody therapeutic created with Genmab&#8217;s HexaBody technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Potential in hematological malignancies; first patient dosed in the first-in-human study in March 2021</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in an exclusive worldwide license and option agreement with Janssen </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">HexaBody-CD38 (GEN3014) is a human CD38 monoclonal antibody product incorporating our HexaBody technology. In preclinical models of hematological malignancies, as presented at ASH in December 2019, HexaBody-CD38 demonstrated enhanced CDC and had shown potent anti-tumor activity. In June 2019, Genmab entered into an exclusive worldwide license and option agreement with Janssen to develop and commercialize HexaBody-CD38. An Investigational New Drug (IND) application was submitted to the U.S. FDA for HexaBody-CD38 in October 2020 followed by Clinical Trial Application (CTA submissions) in Europe in November 2020. The first patient was dosed in the first-in-human study in March 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Quarter 2021 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">March: First patient dosed in first-in-human study of HexaBody-CD38.</font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 12/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Product Candidates Incorporating Genmab&#8217;s Innovation</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;margin:0pt;"><font style="font-size:10pt;">In addition to Genmab&#8217;s own pipeline of product candidates, our innovations are found in the pipelines of other companies that are running clinical development programs with antibodies created by Genmab or created using Genmab&#8217;s DuoBody bispecific antibody technology. </font> <font style="font-size:10pt;">Under these agreements, Genmab is entitled to certain potential milestones and royalties. </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Georgia';font-weight:bold;"><img src="tmb-20210505xex99d1007.jpg" alt="Table&#10;&#10;Description automatically generated" style="display:inline-block;height:260.1pt;width:468pt;"></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 54pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Pre-clinical Programs</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Broad pre-clinical pipeline of around twenty programs </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Pre-clinical pipeline includes both partnered products and in-house programs based on our proprietary technologies or antibodies</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Multiple new INDs expected to be submitted over coming years</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Genmab has entered multiple strategic collaborations to support the expansion of our innovative pipeline, including a broad oncology collaboration with AbbVie</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Our pre-clinical pipeline includes immune effector function enhanced antibodies developed with our HexaBody technology and bispecific antibodies created with our DuoBody<sup style="font-size:7.5pt;vertical-align:top;"> </sup>platform. We are also working with our partners, including AbbVie, BioNTech, Immatics and CureVac N.V. (CureVac), to generate additional new product concepts. A number of the pre-clinical programs are carried out in cooperation with our collaboration partners.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 13/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_SIGNIFICANT_RISKS_AND"></a><a name="SIGNIFICANTRISKSANDUNCERTAINTIES_402181"></a></b><b style="color:#029c93;font-weight:bold;">SIGNIFICANT RISKS AND UNCERTAINTIES</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As a biotech company, Genmab faces a number of risks and uncertainties. These are common for the industry and relate to operations, intellectual property, research and development, commercial and financial activities. For further information about risks and uncertainties, which the Genmab group faces, refer to the 2020 Annual Report and the Form 20-F filed with the U.S. Securities and Exchange Commission (SEC) in March 2021. At the date of this interim report, there have been no significant changes to Genmab&#8217;s overall risk profile since the publication of the Form 20-F; however, the full extent and nature of the impact of the COVID-19 pandemic and related containment measures on our business and financial performance is uncertain as the situation continues to develop. See Genmab&#8217;s Form 20-F for a detailed summary of risks related to our collaborations as well as risks related to the COVID-19 pandemic. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 14/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514646"></a></b><b style="color:#029c93;font-weight:bold;">FINANCIAL REVIEW</b><b style="font-size:16pt;font-weight:bold;"><a name="FINANCIALREVIEW_601130"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="OLE_LINK6"></a><a name="OLE_LINK7"></a>The interim report is prepared on a consolidated basis for the Genmab group. The financial statements are published in Danish Kroner (DKK).</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s revenue was DKK 1,581 million for the first quarter of 2021 compared to DKK 892 million for the first quarter of 2020. The increase of DKK 689 million, or 77%, was primarily driven by higher DARZALEX royalties, the AbbVie milestone of DKK 245 million (USD 40 million) triggered by the first patient dosed in the Phase 3 study of epcoritamab, and the DARZALEX<i style="font-style:italic;"> FASPRO</i> milestone of DKK 184 million (USD 30 million) driven by the first commercial sale in the U.S. for patients with newly diagnosed AL amyloidosis.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:18.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:18.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:18.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Q1 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Q1 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Royalties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 1,017</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 781</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Reimbursement revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 110</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 79</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Milestone revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 454</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 32</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,581</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 892</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Royalties</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Royalty revenue amounted to DKK 1,017 million in the first quarter of 2021 compared to DKK 781 million in the first quarter of 2020. The increase of DKK 236 million, or 30%, was primarily driven by higher DARZALEX royalties achieved under our daratumumab collaboration with Janssen. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net sales of DARZALEX by Janssen were USD 1,365 million in the first quarter of 2021 compared to USD 937 million in the first quarter of 2020. The increase of USD 428 million, or 46%, was driven by the continued strong uptake of DARZALEX. Royalty revenue on net sales of DARZALEX<sup style="font-size:7.5pt;vertical-align:top;"> </sup>was DKK 984 million in the first quarter of 2021 compared to DKK 775 million in the first quarter of 2020, an increase of DKK 209 million. The percentage increase in royalties of 27% is lower than the percentage increase in the underlying net sales primarily due to the lower exchange rate between the USD and DKK in Q1 2021 compared to Q1 2020 and the impact of Janssen&#8217;s continued withholding of a portion of the royalty payments owed to Genmab. Since the second quarter of 2020, Janssen has reduced its quarterly royalty payments to Genmab by what Janssen claims to be Genmab&#8217;s share of Janssen&#8217;s royalty payments to Halozyme in connection with subcutaneous sales. Given the ongoing arbitration, Genmab has reflected this reduction in its royalty revenues each quarter. The impact to Q1 2021 royalties is estimated to be DKK 64 million.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">TEPEZZA (teprotumumab-trbw) was launched by Horizon Therapeutics in the first quarter of 2020. In December 2020, Horizon Therapeutics announced that there was a supply disruption related to the production of TEPEZZA due to U.S. government-mandated COVID-19 vaccine production requirements. Subsequently, in March 2021, Horizon Therapeutics announced its plans to resupply the market beginning in April 2021. Royalties, which are based on net sales, were negligible during the first quarter of 2021 and the first quarter of 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Novartis was granted U.S. FDA approval for Kesimpta (ofatumumab) in relapsing multiple sclerosis and Genmab started recognizing royalties on net sales of Kesimpta during the third quarter of 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Royalties, which are based on net sales, amounted to DKK 31 million for the first quarter of 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 15/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Royalty revenue fluctuations from period to period are due primarily to the level of product net sales as well as foreign currency exchange rates. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Reimbursement Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Reimbursement revenue amounted to DKK 110 million in the first quarter of 2021 compared to DKK 79 million in the first quarter of 2020. The increase of DKK 31 million, or 39%, was primarily driven by higher activities under our collaboration agreement with BioNTech for DuoBody-PD-L1x4-1BB.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Milestone Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk14190762"></a>Milestone revenue was DKK 454 million in the first quarter of 2021 compared to DKK 32 million in the first quarter of 2020, an increase of DKK 422 million, resulting from the achievements described above under our AbbVie and daratumumab collaborations in the first quarter of 2021. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Milestone revenue may fluctuate significantly from period to period due to both the timing of achievements and the varying amount of each individual milestone under our license and collaboration agreements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Financial Statement Note 2 in this interim report for further details about revenue.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Research and Development Costs</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development costs amounted to DKK 848 million in the first quarter of 2021 compared to DKK 715 million in the first quarter of 2020. The increase of DKK 133 million, or 19%, was driven by the continued advancement of multiple projects under our collaborations with AbbVie, Seagen, and BioNTech, and the increase in new employees to support the expansion of our product pipeline. During the first quarter of 2021, Genmab recorded DKK 157 million as a reduction of research and development costs in accordance with Genmab&#8217;s collaboration agreement with AbbVie which was entered into during the second quarter of 2020. Pursuant to this agreement, Genmab and AbbVie share equally in both research and development costs. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development costs accounted for 81% of total operating expenses in the first quarter of 2021 compared to 87% in the first quarter of 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">General and Administrative Expenses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">General and administrative expenses were DKK 201 million in the first quarter of 2021 compared to DKK 106 million in the first quarter of 2020. The increase of DKK 95 million, or 90%, was driven by the increase in new employees as Genmab builds its commercialization capabilities and infrastructure.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">General and administrative expenses accounted for 19% of total operating expenses in the first quarter of 2021 compared to 13% in the first quarter of 2020.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Operating Result </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Operating result was DKK 532 million in the first quarter of 2021 compared to DKK 71 million in the first quarter of 2020. The increase of DKK 461 million was driven by higher revenue, which was partly offset by increased operating expenses.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Net Financial Items</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net financial items for the first quarter of 2021 were a gain of DKK 892 million compared to a gain of DKK 283 million in the first quarter of 2020. <a name="OLE_LINK26"></a><a name="OLE_LINK27"></a>The increase of DKK 609 million was primarily driven by the strengthening of the USD against the DKK on Genmab&#8217;s U.S. denominated portfolio and cash holdings, </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 16/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">and an increase in fair value of Genmab&#8217;s investment in common shares of CureVac. Refer to Financial Statement Note 4 in this interim report for further details about the net financial items.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Corporate Tax</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Corporate tax expense for the first quarter of 2021 was DKK 328 million compared to DKK 85 million for the first quarter of 2020. The increase in corporate tax expense is primarily the result of higher net result before tax. The effective tax rate in the first quarter of 2021 was 23% compared to 24% in the first quarter of 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Net Result </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net result for the first quarter of 2021 was DKK 1,096 million compared to DKK 269 million in the first quarter of 2020. The increase was driven by the items described above. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Cash Position </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Cash Position (DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 10,191</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 8,819</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 7,892</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 7,260</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Cash position</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 18,083</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 16,079</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2021, cash, cash equivalents and marketable securities (cash position) amounted to DKK 18,083 million, an increase of DKK 2,004 million, or 12%, from the beginning of 2021. The increase was primarily driven by net exchange rate gains of DKK 783 million due to the strengthening of the USD, operating result of DKK 532 million, changes in operating assets and liabilities of DKK 500 million primarily due to DARZALEX royalties recognized in the fourth quarter of 2020, which were received in 2021, and proceeds received of DKK 361 million from the sale of a portion of our CureVac shares during the first quarter of 2021, partly offset by cash payments for the purchase of treasury shares of DKK 190 million during the first quarter of 2021. Refer to Financial Statement Note 3 in this interim report for further details about the sale of CureVac shares. Refer to Financial Statement Note 5 in this interim report for further details about the purchase of treasury shares.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2021, Genmab&#8217;s USD denominated cash, cash equivalents and marketable securities represents 82% of Genmab&#8217;s cash position compared to 83% as of December 31, 2020.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Cash and cash equivalents included short-term marketable securities of DKK 1,938 million at the end of March 2021, compared to DKK 2,206 million at the end of December 2020. In accordance with our accounting policy, securities purchased with a maturity of less than three months at the date of acquisition are classified as cash and cash equivalents. Refer to Financial Statement Note 3 in this interim report for further details about our marketable securities.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Cash Flow</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:15.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Cash Flow (DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Q1 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:15.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Q1 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:63.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash provided by operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 1,185</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 1,914</font></p></td></tr><tr><td style="vertical-align:bottom;width:63.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash (used in) provided by investing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> (579)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 9</font></p></td></tr><tr><td style="vertical-align:bottom;width:63.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash (used in) provided by financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> (220)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 15</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net cash provided by operating activities is primarily related to our operating result, changes in operating assets and liabilities, reversal of net financial items, and adjustments related to non-cash transactions. In the first quarter of 2021, as compared to the first quarter of 2020, the primary driver of lower cash provided by operating activities was due to decreased changes in operating assets and liabilities related </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 17/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">to non-recurring DARZALEX milestones of DKK 1.7 billion achieved in the fourth quarter of 2019 that were received in 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The change in cash used in investing activities primarily reflects differences between the proceeds received from sale and maturity of our investments and amounts invested, and the investment in tangible assets. Purchases of marketable securities exceeded sales and maturities in the first quarter of 2021 but remained flat in the first quarter of 2020. For the first quarter of 2021, investing activities also includes the proceeds from the sale of CureVac shares of DKK 361 million.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="background-color:#ffff00;font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net cash used in financing activities is primarily related to the exercise of warrants, purchase of treasury shares, lease payments, and payment of withholding taxes on behalf of employees on net settled RSUs. In the first quarter of 2021, the primary driver of the cash used in financing activities was&#160;related to cash payments for the purchase of treasury shares of DKK 190 million.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Balance Sheet</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2021, total assets were DKK 22,210 million compared to DKK 21,143 million on December 31, 2020. As of March 31, 2021, assets are mainly comprised of a cash position of DKK 18,083 million and current receivables of DKK 1,854 million. The current receivables consist primarily of amounts related to royalties and milestones from our collaboration agreements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2021, total liabilities were DKK 2,115 million compared to DKK 2,022 million on December 31, 2020. The increase in total liabilities of DKK 93 million, or 5%, was primarily driven by corporate tax payable of DKK 70 million and an increase in lease liabilities of DKK 59 million related to the commencement of a lease in Japan.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Shareholders&#8217; equity as of March 31, 2021 was DKK 20,095 million compared to DKK 19,121 million on December 31, 2020. The increase of DKK 974 million, or 5%, was driven primarily by Genmab&#8217;s net result and the issuance of shares related to the share-based compensation plans, partly offset by the purchase of treasury shares. Genmab&#8217;s equity ratio remained unchanged at 90% as of March 31, 2021 compared to December 31, 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Employees</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2021, the total number of employees was 871 compared to 579 employees as of March 31, 2020. The increase in employees was driven primarily by the expansion and acceleration of our pipeline, as well as investment in commercialization capabilities.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Employees</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:21.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Research and development employees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:21.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">709</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 490</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">General and administrative employees*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:21.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">162</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 89</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total employees</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:21.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 871</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 579</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">*Includes commercialization capabilities</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 18/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Legal Matter &#8211; Janssen Binding Arbitration </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In September 2020, Genmab commenced binding arbitration of two matters arising under its license agreement with Janssen Biotech, Inc. (Janssen) relating to daratumumab. Under the license agreement, Genmab is, among other things, entitled to royalties from Janssen on sales of daratumumab (marketed as DARZALEX for intravenous administration and as DARZALEX <i style="font-style:italic;">FASPRO</i> in the United States and as DARZALEX SC in Europe for subcutaneous administration). The arbitration first is to settle whether Genmab is required to share in Janssen&#8217;s royalty payments to Halozyme Therapeutics, Inc. for the Halozyme enzyme technology used in the subcutaneous formulation of daratumumab. The royalties Janssen pays to Halozyme represent a mid-single digit percentage rate of subcutaneous daratumumab sales. Janssen has started reducing its royalty payments to Genmab by what it claims to be Genmab&#8217;s share of Janssen&#8217;s royalty payments to Halozyme beginning in the second quarter of 2020 and has continued to do so through March 31, 2021. Given the ongoing arbitration, Genmab has reflected this reduction in its royalty revenues each quarter. The impact to Q1 2021 royalties is estimated to be DKK 64 million. The arbitration is also to settle whether Janssen&#8217;s obligation to pay royalties on sales of licensed product extends, in each applicable country, until the expiration or invalidation of the last-to-expire relevant Genmab-owned patent or the last-to-expire relevant Janssen-owned patent covering the product, as further defined and described in the license agreement. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 19/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514647"></a></b><b style="color:#029c93;font-weight:bold;">STATEMENT OF COMPREHENSIVE INCOME FOR THE FIRST QUARTER OF </b><b style="font-size:16pt;font-weight:bold;"><a name="STATEMENTOFCOMPREHENSIVEINCOMEFORTHE3RDQ"></a></b><b style="color:#029c93;font-weight:bold;">2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Income Statement</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">1st&#160;Quarter of</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">1st&#160;Quarter of</p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2020</p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Revenue</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,581</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 892</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (848)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (715)</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">General and administrative expenses</p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (201)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (106)</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating expenses</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (1,049)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (821)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating result</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 532</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 71</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Financial income</p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 968</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 285</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Financial expenses</p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (76)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2)</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net result before tax</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,424</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 354</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Corporate tax</p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (328)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (85)</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net result</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,096</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 269</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Basic net result per share</p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16.76</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4.13</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Diluted net result per share</p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16.61</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4.09</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Statement of Comprehensive Income</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net result</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,096</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 269</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Other comprehensive income:</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amounts which will be re-classified to the income statement:</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Adjustment of foreign currency fluctuations on subsidiaries</p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.1%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,137</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 278</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Toc16514648"></a><a name="FIRSTNINEMONTHSOF2019_377366"></a><a name="_MON_1411968110"></a><a name="_Toc16514649"></a><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 20/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="BALANCESHEET_757698"></a></b><b style="color:#029c93;font-weight:bold;">BALANCE SHEET</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_MON_1411968448"></a><a name="_MON_1428926110"></a><a name="_Toc16514650"></a><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">March&#160;31,&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">December&#160;31,&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">2020</p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">ASSETS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 317</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 338</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 505</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 453</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 337</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 283</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 32</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 177</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 177</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 905</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,081</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total non-current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,273</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,352</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Corporate tax receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 249</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,854</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,463</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,191</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,819</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,892</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,260</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 19,937</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 18,791</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 22,210</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 21,143</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">SHAREHOLDERS&#8217; EQUITY AND LIABILITIES</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share premium</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 11,914</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 11,894</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other reserves</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 95</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 54</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Retained earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,020</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,107</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Shareholders&#39; equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 20,095</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 19,121</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Provisions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 326</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 277</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 487</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 487</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total non-current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 822</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 769</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Corporate tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 70</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 52</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 42</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 26</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 26</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,145</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,185</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,293</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,253</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,115</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,022</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total shareholders&#39; equity and liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 22,210</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 21,143</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share-based instruments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Related parties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Subsequent events to the balance sheet date</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 21/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="color:#029c93;font-weight:bold;">STATEMENT OF CASH FLOWS</b><b style="font-size:16pt;font-weight:bold;"><a name="STATEMENTOFCASHFLOWS_489627"></a><a name="_Toc16514651"></a></b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">1st Quarter</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">1st Quarter</p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:8.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">March&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">March&#160;31,&#160;2020</p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net result before tax</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,424</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 354</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Reversal of financial items, net</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (892)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (283)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Adjustments for non-cash transactions</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 117</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 87</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Changes in operating assets and liabilities</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 500</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,824</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from operating activities before financial items</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,149</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,982</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest received</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 39</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 33</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest elements of lease payments</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest paid</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Corporate taxes paid</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (97)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from operating activities</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,185</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,914</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Investment in tangible assets</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (28)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (58)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Marketable securities bought</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,673)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (5,812)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Marketable securities sold</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,769</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,879</font></p></td></tr><tr><td style="vertical-align:middle;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Other investments bought</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (8)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:middle;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Other investments sold</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">3, 4 </p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 361</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from investing activities</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (579)</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 9</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Warrants exercised</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 37</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Principal elements of lease payments</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (12)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (8)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Purchase of treasury shares</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (190)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Payment of withholding taxes on behalf of employees on net settled RSUs</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (38)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (14)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from financing activities</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (220)</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 15</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Change in cash and cash equivalents</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 386</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,938</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Cash and cash equivalents at the beginning of the period</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,260</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,552</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Exchange rate adjustments</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 246</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 53</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents at the end of the period</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 7,892</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,543</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents include:</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Bank deposits</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,954</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,835</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Short-term marketable securities</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,938</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,708</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents at the end of the period</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:15.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 7,892</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,543</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 22/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">STATEMENT OF CHANGES IN EQUITY</b><b style="font-size:16pt;font-weight:bold;"><a name="STATEMENTOFCHANGESINEQUITY_43137"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Translation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Retained</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Shareholders&#39;</p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">premium</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">reserves</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">equity</p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at December 31, 2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 65</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,755</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 98</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,130</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 14,048</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net result</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 269</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 269</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 269</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 278</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Transactions with owners:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Exercise of warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share-based compensation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 45</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 45</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net settlement of RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (14)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (14)</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at March 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 65</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,796</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 107</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,430</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 14,398</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at December 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,894</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 54</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 7,107</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 19,121</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net result</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,096</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,096</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,096</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,137</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Transactions with owners:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Exercise of warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Purchase of treasury shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (206)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (206)</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share-based compensation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 61</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 61</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net settlement of RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (38)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (38)</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at March 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,914</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 95</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 8,020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 20,095</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Toc16514652"></a><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 23/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">NOTES TO THE FINANCIAL STATEMENTS</b><b style="font-size:16pt;font-weight:bold;"><a name="NOTESTOTHEFINANCIALSTATEMENTS_435403"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 1 &#8211; Basis of Presentation</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Accounting Policies</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The interim financial statements have been prepared in accordance with IAS 34 as issued by the International Accounting Standards Board (IASB) and in accordance with IAS 34 as endorsed by the EU and additional Danish disclosure requirements for interim reports of listed companies. The interim report has not been reviewed or audited by Genmab&#8217;s external auditors. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The interim report has been prepared using the same accounting policies as outlined in Section 1 &#8211; Basis of Presentation in the financial statements in the Genmab 2020 Annual Report (Annual Report). A number of new or amended standards became applicable for the current reporting period. Genmab did not have to change its accounting policies as a result of adopting these standards. Certain reclassifications have been made to the prior year presentation. These interim financial statements should be read in conjunction with the Annual Report.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Management Judgements and Estimates under IFRS</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In preparing interim reports, certain provisions under IFRS require management to make judgements (various accounting estimates and assumptions), which may significantly impact the group&#8217;s financial statements. For a description of significant judgements and estimates, refer to Note 1.3 in the Annual Report.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Information about Geographical Areas</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab is managed and operated as one business unit, which is reflected in the organizational structure and internal reporting. No separate lines of business or separate business entities have been identified with respect to any of the product candidates or geographical markets and no segment information is currently prepared for internal reporting. Refer to Note 2.2 in the Annual Report for further details.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 24/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_MON_1428393242"></a><a name="_MON_1428926213"></a><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 2 &#8211; Revenue </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab enters into license and collaboration agreements that are within the scope of IFRS 15, under which it licenses certain rights to its product candidates to third parties and also may participate in the development of the product candidates. The terms of these arrangements typically include payment to Genmab of one or more of the following: non-refundable, upfront license fees; exclusive designation fees; annual license maintenance fees; additional target fees; development, regulatory and commercial milestone payments; payments for research and development services; and royalties on net sales of licensed products. Each of these payments results in revenue from contracts with customers. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In September 2020, Genmab commenced binding arbitration of two matters arising under its license agreement with Janssen Biotech, Inc. (Janssen) relating to daratumumab. Under the license agreement, Genmab is, among other things, entitled to royalties from Janssen on sales of daratumumab (marketed as DARZALEX for intravenous administration and as DARZALEX <i style="font-style:italic;">FASPRO</i> in the United States and as DARZALEX SC in Europe for subcutaneous administration). The arbitration first is to settle whether Genmab is required to share in Janssen&#8217;s royalty payments to Halozyme Therapeutics, Inc. for the Halozyme enzyme technology used in the subcutaneous formulation of daratumumab. The royalties Janssen pays to Halozyme represent a mid-single digit percentage rate of subcutaneous daratumumab sales. Janssen has started reducing its royalty payments to Genmab by what it claims to be Genmab&#8217;s share of Janssen&#8217;s royalty payments to Halozyme beginning in the second quarter of 2020 and has continued to do so through March 31, 2021. Given the ongoing arbitration, Genmab has reflected this reduction in its royalty revenues each quarter. The impact to Q1 2021 royalties is estimated to be DKK 64 million. The arbitration is also to settle whether Janssen&#8217;s obligation to pay royalties on sales of licensed product extends, in each applicable country, until the expiration or invalidation of the last-to-expire relevant Genmab-owned patent or the last-to-expire relevant Janssen-owned patent covering the product, as further defined and described in the license agreement.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The table below summarizes Genmab&#8217;s revenue by type and collaboration partner under Genmab&#8217;s agreements. This information provides the reader additional information regarding the nature, amount, timing and uncertainty of Genmab&#8217;s revenue and how cash flows might be affected by economic factors.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">1st Quarter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">1st Quarter</p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">March&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">March&#160;31,&#160;2020</p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Revenue by type:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Royalties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,017</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 781</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Reimbursement revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 110</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 79</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Milestone revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 454</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 32</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,581</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 892</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Revenue by collaboration partner:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Janssen</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,193</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 775</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">AbbVie</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 245</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Seagen</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 39</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 49</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">BioNTech</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 71</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 30</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Novartis</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 31</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Other collaboration partners</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 32</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,581</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 892</b></p></td></tr></table></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 25/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;margin:0pt;"><b style="color:#029c93;font-size:10pt;font-weight:bold;">Note 3 &#8211; Financial Instruments</b>o<font style="font-size:10pt;"> </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March&#160;31,&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">December&#160;31,&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:50.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:50.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:50.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,191</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,819</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Other investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 905</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,081</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Financial assets measured at fair value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,096</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 9,900</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2021, our marketable securities were administrated by two external investment managers. The guidelines and investment managers are reviewed regularly to reflect changes in market conditions, Genmab&#8217;s activities and financial position. During the first quarter of 2021, Genmab&#8217;s investment policy was amended to allow investments in debt rated BBB- or greater by S&amp;P or Fitch and in debt rated Baa3 or greater by Moody&#8217;s.&#160;The amended policy also includes additional allowable investment types, none of which were purchased during the first quarter of 2021.&#160; </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s current portfolio is spread over a number of different securities with a focus on liquidity and security. Genmab&#8217;s total marketable securities were invested in EUR (9%), DKK (16%), USD (74%) and GBP (1%) denominated securities as of March 31, 2021, compared to 10%, 19%, 70%, and 1%, as of December 31, 2020.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2021 and December 31, 2020, 99% of our marketable securities had an AA rating or higher from Moody&#8217;s, S&amp;P, or Fitch. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Fair Value Measurement </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">For financial instruments that are measured in the balance sheet at fair value, IFRS 13 for financial instruments requires disclosure of fair value measurements by level of the following fair value measurement hierarchy for: </p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Level 1 &#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Level 2 &#8211; Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices)</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="color:#000000;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Level 3 &#8211; Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs).</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:22.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:22.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:36.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:36.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:22.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Assets Measured at Fair Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:22.19%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-size:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:22.19%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,191</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,191</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,819</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,819</font></p></td></tr><tr><td style="vertical-align:bottom;width:22.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;">Other investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 883</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 22</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 905</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,067</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 14</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,081</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Marketable Securities</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">All fair values are determined by reference to external sources using unadjusted quoted prices in established markets for our marketable securities (Level 1). </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 26/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Other Investments </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Other investments as of March 31, 2021 consist primarily of a DKK 883 million investment in common shares of CureVac, compared to DKK 1,067 million as of December 31, 2020. During March 2021, Genmab sold 30% of its investment in common shares of CureVac. Proceeds received from the sale of shares were DKK 361 million. The investment in CureVac is recorded at fair value through profit and loss. The fair value of Genmab&#8217;s investment in common shares of CureVac is determined using unadjusted quoted prices in established markets (Level 1).</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 4 &#8211; Financial Income and Expenses</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">1st Quarter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">1st Quarter</p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March&#160;31,&#160;2020</p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Financial income:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest and other financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 62</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Gain on marketable securities, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 27</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Gain on other investments, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 123</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Foreign exchange rate gain, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 783</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 217</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total financial income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 968</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 285</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Financial expenses:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest and other financial expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2)</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Loss on marketable securities, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (73)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total financial expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (76)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (2)</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net financial items</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 892</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 283</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Foreign exchange rate gain, net of DKK 783 million in the first quarter of 2021 and DKK 217 million in the first quarter of 2020 was driven by the strengthening of the USD against the DKK that positively impacted our USD denominated marketable securities portfolio and cash holdings each period. Refer to Note 4.2 in the Annual Report for further details of foreign currency risk.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Gain on other investments, net of DKK 123 million in the first quarter of 2021 was driven by the increase in fair value of Genmab&#8217;s investment in common shares of CureVac. There was no gain or loss attributable to other investments during the first quarter of 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 5 &#8211; Share-Based Instruments</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Restricted Stock Unit Program</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab A/S established a Restricted Stock Unit (RSU) program as an incentive for all the Genmab group&#8217;s employees, members of the Executive Management, and members of the Board of Directors. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">For details of the RSU program prior to changes in 2021, refer to Note 4.6 in the Annual Report.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In February 2021, the RSU program was amended (the &#8220;2021 RSU Program&#8221;). Under the terms of the 2021 RSU Program, the Board may decide, in its sole discretion, to accelerate the vesting of the RSUs held by a participant, or accelerate the vesting of the RSUs and make a cash settlement in case of (1) a </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 27/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">change of control event as defined in the 2021 RSU Program, if a participant&#8217;s employment terms are materially changed to his or her detriment during the 12-month period following the change in control event, or if the participant, who is a member of the Board, is replaced by a new board member or such participant&#39;s seat on the Board is eliminated due to a reduction in the number of board members, or (2) certain other extraordinary transactions as described in the 2021 RSU Program. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Under the terms of the 2021 RSU Program, in the event an RSU holder separates from the Company under circumstances in which the RSU holder is considered a &#8220;bad-leaver,&#8221; such as being dismissed for cause or during the employment probationary period, unvested RSU will be forfeited. RSU holders may maintain a pro rata portion of unvested RSUs if they separate from the Company under circumstances where they are considered &#8220;good-leavers,&#8221; such as dismissal without cause or termination of employment due to the Company&#8217;s material breach of the RSU holder&#8217;s employment terms, or if the participant is a member of the Board, if the membership of the Board ceases for any other reason than as a result of the participants death. All unvested RSUs will be forfeited in the event of termination of employment due to the RSU holder&#8217;s death.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first quarter of 2021, 128,406 RSUs were granted with a weighted average fair value of DKK 2,084.65 per RSU. During the first quarter of 2020, 17,690 RSUs were granted with a weighted average fair value of DKK 1,362.50 per RSU. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first quarter of 2021, 44,109 RSUs vested, compared to 31,484 RSUs during the first quarter of 2020. Genmab settles RSUs using shares issued from treasury stock. A portion of the settlement is withheld to satisfy individual statutory tax withholding obligations which remain in our treasury share account.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Warrant Program</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab A/S established warrant programs as an incentive for all the Genmab group&#8217;s employees, and members of the Executive Management. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">For details of the warrant programs prior to changes in 2021, refer to Note 4.6 in the Annual Report.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;">In February 2021, the Warrant Program was amended (the &#8220;2021 Warrant Program&#8221;). Under the terms of the 2021 Warrant Program, the Board may decide, in its sole discretion, to accelerate the vesting of the warrants held by a warrant holder in case of (1) a change of control event as defined in the 2021 Warrant Program, if a warrant holder&#8217;s employment terms are materially changed to his or her detriment during the 12-month period following a change in control event, or (2) certain other extraordinary transactions as described in the 2021 Warrant Program.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;">Under the 2021 Warrant Program, if a warrant holder separates from the Company under circumstances in which the warrant holder is considered a &#8220;bad-leaver,&#8221; such as being dismissed for cause or during the employment probationary period, unvested warrants will be forfeited. Warrant holders may maintain a pro rata portion of unvested warrants if they separate from the Company under circumstances where they are considered &#8220;good-leavers,&#8221; such as dismissal without cause or termination of employment due to the Company&#8217;s material breach of the warrant holder&#8217;s employment terms. All unvested warrants will be forfeited in the event of termination of employment due to the warrant holder&#8217;s death.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first quarter of 2021, 114,158 warrants were granted to our employees with a weighted average exercise price of DKK 2,122.57 per warrant and a weighted average Black-Scholes fair market value of DKK 663.95 per warrant. During the first quarter of 2020, 33,678 warrants were granted to our </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 28/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">employees with a weighted average exercise price of DKK 1,362.50 per warrant and a weighted average Black-Scholes fair market value of DKK 393.72 per warrant.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;">During the first quarter of 2021, 41,574 warrants were exercised with a weighted average exercise price on date of grant of DKK 478.94 with proceeds to Genmab of DKK 20 million. The warrants exercised increased share capital accordingly and corresponded to approximately 0.06% of share capital. During the first quarter of 2020, 136,501 warrants were exercised with a weighted average exercise price on date of grant of DKK 303.27 with proceeds to Genmab of DKK 41 million. The warrants exercised increased share capital accordingly and corresponded to approximately 0.21% of share capital.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Share-based compensation expense</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Share-based compensation expenses related to our RSU and warrant programs for the first quarter of 2021 totaled DKK 61 million compared to DKK 45 million for the first quarter of 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br><b style="font-weight:bold;">Share repurchases</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In general, Genmab intends to purchase its own shares in order to cover a portion of the obligations in relation to RSUs. Authorization to purchase our shares up to a nominal value of DKK 500,000 (500,000 shares) was given by the shareholders at the annual general meeting in March&#160;2016. As of December 31, 2020, a total of 225,000 shares, with a nominal value of DKK 225,000, had been repurchased under the March 2016 authorization. The March 2016 authorization expired in March 2021. Additionally, in March&#160;2019, Genmab shareholders authorized us to repurchase up to an additional nominal value of DKK 500,000 (500,000 shares). A portion of the shares that may be repurchased under this authorization may be used to cover our obligations in relation to the RSUs. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As announced on February 23, 2021, Genmab initiated a share buy-back program. During the first quarter of 2021, Genmab acquired 100,000 of its own shares, representing approximately 0.2% of share capital. The total amount paid to acquire the shares, including directly attributable costs, was DKK 206 million and has been recognized as a deduction to shareholders&#8217; equity. These shares are classified as treasury shares and are presented within retained earnings on the balance sheet as of March 31, 2021. There were no share repurchases during the first quarter of 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2021, 202,977 treasury shares were held by Genmab to cover the obligations in relation to the RSU program and to mitigate the dilutive effect of share capital increases resulting from future exercises of warrants.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 29/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 6 &#8211; Related Parties</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s related parties are the Genmab A/S&#8217; (parent company) subsidiaries, Board of Directors, Executive Management, and close members of the family of these persons. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Transactions with Related Parties</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first quarter of 2021, there were no material related party transactions. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab has service agreements with, and has made equity compensation grants to, members of Executive Management in the ordinary course of business.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Key Changes to Executive Management and the Board of Directors</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2021, there was one change to the Executive Management team. Effective March 1, 2021, Tahamtan Ahmadi, previously Senior Vice President, Head of Oncology, was appointed Executive Vice President and Chief Medical Officer, Head of Experimental Medicines. He joins the existing Executive Management team of Jan van de Winkel, President and Chief Executive Officer, Judith Klimovsky, Executive Vice President and Chief Development Officer, Anthony Pagano, Executive Vice President and Chief Financial Officer and Anthony Mancini, Executive Vice President and Chief Operating Officer. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">There were no changes to the Board of Directors as of March 31, 2021. The Board of Directors is comprised of five independent board members, one non-independent board member, and three employee-elected board members. They are Deirdre P. Connelly (Chair), Pernille Erenbjerg (Deputy Chair), Rolf Hoffmann, Dr. Paolo Paoletti, Jonathan Peacock, Dr. Anders Gersel Pedersen, Peter Storm Kristensen, Dr. Mijke Zachariasse and Rima Bawarshi <font style="white-space:pre-wrap;">Nassar, respectively.  </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 30/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 7 &#8211; Leases</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amounts recognized in the balance sheet</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The balance sheet shows the following amounts relating to leases:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March&#160;31,&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">December&#160;31,&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2020</p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Properties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 334</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 280</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;">337</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 283</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Lease liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 52</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 42</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Non-current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 326</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 277</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total lease liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 378</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 319</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first quarter of 2021, there were additions to our right-of-use assets and lease liabilities related to the commencement of a lease in Japan with respect to office space. There were no additions to the right-of-use assets and lease liabilities during the first quarter of 2020.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Significant leases not yet commenced</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During 2020, Genmab entered into a lease agreement with respect to the new headquarters in Denmark with a commencement date in March 2023 and is non-cancellable until March 2038. The total future minimum payments over the term of the lease are approximately DKK 342 million and estimated capital expenditures to fit out the space are approximately DKK 40 million. Additionally, Genmab amended a lease agreement for additional office and laboratory space in the United States with a commencement date in April 2021, which is non-cancellable until August 2031. The total future minimum payments over the term of the lease are approximately DKK 91 million and estimated capital expenditures to fit out the space are approximately DKK 56 million.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During 2019, Genmab entered into a lease agreement with respect to office and laboratory space in the Netherlands with a commencement date in February 2022 and is non-cancellable until January 2032. The total future minimum payments over the term of the lease are approximately DKK 117 million and estimated capital expenditures to fit out the space are approximately DKK 74 million.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 31/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amounts recognized in the statement of comprehensive income</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The statement of comprehensive income shows the following amounts relating to leases:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:51.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">1st Quarter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">1st Quarter</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March&#160;31,&#160;2020</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Depreciation charge of right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Properties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 11</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total depreciation charge of right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Expense relating to short-term leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest expense is included in net financial items and expenses relating to short-term leases are included in operating expenses in the statement of comprehensive income.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 8 - Subsequent Events to the Balance Sheet Date</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">No events have occurred subsequent to the balance sheet date that could significantly affect the financial statements as of March 31, 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 32/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514653"></a></b><b style="color:#029c93;font-weight:bold;">ABOUT GENMAB</b><b style="font-size:16pt;font-weight:bold;"><a name="ABOUTGENMAB_556806"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:7.5pt;font-style:italic;">Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation antibody technologies, expertise in antibody biology, translational research and data sciences and strategic partnerships. To create novel therapies, Genmab utilizes its next-generation antibody technologies, which are the result of its collaborative company culture and a deep passion for innovation. Genmab&#8217;s proprietary pipeline consists of modified antibody candidates, including bispecific T-cell engagers and next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. The company is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit Genmab.com.</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:7.5pt;font-style:italic;">This Interim Report contains forward looking statements. The words &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;anticipate&#8221;, &#8220;intend&#8221; and &#8220;plan&#8221; and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with pre-clinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab&#8217;s most recent financial reports, which are available on www.genmab.com and the risk factors included in Genmab&#8217;s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Genmab does not undertake any obligation to update or revise forward looking statements in this Interim Report nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law. </i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:7.5pt;font-style:italic;">Y-shaped Genmab logo</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; HuMax&#174;; DuoBody</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; DuoBody in combination with the DuoBody logo</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; HexaBody</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; HexaBody in combination with the HexaBody logo</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; DuoHexaBody</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; and HexElect</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">. Kesimpta</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> and Sensoready</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> are trademarks of Novartis AG or its affiliates. DARZALEX</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> and DARZALEX FASPRO</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> are trademarks of Johnson &amp; Johnson. TEPEZZA</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> is a trademark of Horizon Therapeutics Ireland DAC. </i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 33/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20210505xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514654"></a></b><b style="color:#029c93;font-weight:bold;">DIRECTORS&#8217; AND MANAGEMENT&#8217;S STATEMENT ON THE INTERIM REPORT</b><b style="font-size:16pt;font-weight:bold;"><a name="DIRECTORSANDMANAGEMENTSSTATEMENTONTHEINT"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;">The Board of Directors and the Executive Management have today considered and adopted the unaudited interim report of the Genmab group for the quarter ended March 31, 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;">The interim report is prepared in accordance with IAS 34, &#8220;Interim Financial Reporting,&#8221; as issued by the IASB and in accordance with IAS 34 as endorsed by the EU, and additional Danish disclosure requirements for interim reports of listed companies.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;">We consider the applied accounting policies to be appropriate and, in our opinion, the interim report gives a true and fair view of the assets and liabilities, financial position, results of operation and cash flows of the group.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;margin:0pt 0pt 11pt 0pt;">Furthermore, we consider the Management&#8217;s Review to give a true and fair account of the development in the group&#8217;s activities and financial affairs, results of operations and the group&#8217;s financial position as a whole as well as a description of the significant risks and uncertainties which the group faces, as further described in our 2020 Annual Report and the Form 20-F filed with the U.S. Securities and Exchange Commission in March 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Copenhagen, May 5, 2021</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:bold;text-indent:0pt;margin:12pt 0pt 3pt 0pt;"><b style="color:#029c93;font-style:normal;font-weight:bold;">Executive Management</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-1.469017%;padding-left:0pt;padding-right:0pt;width:102.93%;" align="center"><tr style="height:1.25pt;"><td style="vertical-align:bottom;width:19.39%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:bottom;width:18.5%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:bottom;width:17.57%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:top;width:19.46%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:bottom;width:25.06%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr style="height:14.7pt;"><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1008.jpg" alt="A picture containing hanger&#10;&#10;Description automatically generated" style="display:inline-block;height:34.2pt;left:0%;padding-bottom:0.3pt;position:relative;top:0pt;width:66pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1009.jpg" alt="A picture containing text, opener, clipart, tool&#10;&#10;Description automatically generated" style="display:inline-block;height:29.57pt;left:0%;padding-bottom:0.45pt;position:relative;top:0pt;width:77.4pt;"></p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1010.jpg" alt="A picture containing hanger&#10;&#10;Description automatically generated" style="display:inline-block;height:34.3pt;left:0%;padding-bottom:0.2pt;position:relative;top:0pt;width:58.8pt;"></p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1011.jpg" alt="Graphic" style="display:inline-block;height:33.28pt;width:79.8pt;"></p></td><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1012.jpg" alt="A picture containing sky&#10;&#10;Description automatically generated" style="display:inline-block;height:30.05pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:77.4pt;"></p></td></tr><tr style="height:14.7pt;"><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Jan van de Winkel</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Anthony Pagano</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Judith Klimovsky</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Anthony Mancini</p></td><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Tahamtan Ahmadi</p></td></tr><tr style="height:13.95pt;"><td colspan="2" style="vertical-align:top;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(President &amp; CEO)</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; CFO)</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; CDO)</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; COO)</p></td><td style="vertical-align:top;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; CMO)</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:bold;padding-left:28.8pt;text-indent:-28.8pt;margin:12pt 0pt 3pt 0pt;"><b style="color:#029c93;font-style:normal;font-weight:bold;">Board of Directors</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:3.4pt;"><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><div style="height:3.4pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><div style="height:3.4pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><div style="height:3.4pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"></td></tr><tr style="height:45.85pt;"><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1013.jpg" alt="Graphic" style="display:inline-block;height:44.4pt;left:0%;padding-bottom:0.6pt;position:relative;top:0pt;width:77.32pt;"></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1014.jpg" alt="Graphic" style="display:inline-block;height:25.56pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:88.2pt;"></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1015.jpg" alt="Graphic" style="display:inline-block;height:22.97pt;width:111.6pt;"></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Deirdre P. Connelly</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Pernille Erenbjerg </p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Anders Gersel Pedersen</p></td></tr><tr><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Chair)</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Deputy Chair)</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1016.jpg" alt="A picture containing text&#10;&#10;Description automatically generated" style="display:inline-block;height:28.38pt;left:0%;padding-bottom:0.15pt;position:relative;top:0pt;width:98.4pt;"></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1017.jpg" alt="Graphic" style="display:inline-block;height:34.46pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:71.4pt;"></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1018.jpg" alt="Text, letter&#10;&#10;Description automatically generated" style="display:inline-block;height:34.32pt;left:0%;padding-bottom:0.2pt;position:relative;top:0pt;width:76.8pt;"></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Rolf Hoffmann</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Paolo Paoletti</p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Jonathan Peacock</p></td></tr><tr style="height:29.2pt;"><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1019.jpg" alt="Text, letter&#10;&#10;Description automatically generated" style="display:inline-block;height:33pt;width:71pt;"></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1020.jpg" alt="A picture containing text&#10;&#10;Description automatically generated" style="display:inline-block;height:25.15pt;left:0%;padding-bottom:0.35pt;position:relative;top:0pt;width:112.07pt;"></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20210505xex99d1021.jpg" alt="Graphic" style="display:inline-block;height:21pt;width:120pt;"></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Mijke Zachariasse</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Rima Bawarshi Nassar</p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Peter Storm Kristensen</p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Employee elected)</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Employee elected)</p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Employee elected)</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:fixed;width:100%;" align="center"><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 36</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 34/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tmb-20210505xex99d1016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Z ,<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HI
MH92Q4'D=1Z4Z@ HHIH=22 02O7GI0 ZBH;><7 9E!V!BH;^]BIJ $-(CJXRI
M!'J*HZG<O&D5M!C[1<-M3_9'\3?@*M6T$=M;I#&,(@P*+:7 FJH+EI-0-O&J
MF.-<ROGH3T _G46JZ@;*V;RE#SD?(OOZFHHBFB:1OG8O*?F<]Y)#_P#7XJE'
M2X&F&4MMR-W7%.JCIUM)%&T]P<W,WS/_ +/HH^E7JEZ %%%% !1110 4444
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>1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tmb-20210505xex99d1009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !  *<# 2(  A$! Q$!_\0
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MY;&D71D _A4R1X)^I&*[.L/0O"MCH5S<WB2W5W?W0 GO;R7S)7 Z+G   ]
/*W*&P"BBBD 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tmb-20210505xex99d1007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" () Z@# 2(  A$! Q$!_\0
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MV%Y(8[:\MIG R5BE5CCZ U;KP"PMO#MOX.\%76CBPB\4->6J[K1E\]\G]X)
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M.!@,,#KCO6E10!0CT/28KV:]CTRR2ZF!66=8%#N/1FQDU%;>&]"LRQM=&T^
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M)?(<21>9&&\MAT*YZ'W%5H_#VBQ7OVV/2+!+LOYGGK;('WXQNW8SG!/-:5%
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MB8&S/;D]N]=$X8J=I ;'!-<?9:/J]QXEL]1O;&QM9K7>L][;2?->*00J[<9
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M_<:]%9'G^(/^?'3_ /P*?_XBD\_Q!_SXZ?\ ^!3_ /Q%%@]JNS^XV**Q_/\
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M!_SXZ?\ ^!3_ /Q%%@]JNS^XV**Q_/\ $'_/CI__ (%/_P#$4>?X@_Y\=/\
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M&K_8+'#$@?Z2W;_@%-_MW6/^@?9?^!+?_$4<C#ZU3\_N9TV:,US/]NZQ_P!
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M%'(QK%0??[F=)2$ @@@$5D>?X@_Y\=/_ / I_P#XBC[1K_\ SXZ=_P"!3?\
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ML^9N,DH/'+<+P !4GAWP/=V5OX,WZ'Y4WV2]@U5F1>0Z,$67^\,XP#D#VHZ
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M/2[BQO=>NAIDFE:9=W*/9V,BJACPF';8I(7<>WMFNVH **** "BBB@ HHHH
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M[UWXSMSSCZ4B2QR$A'5B.H!SBO*K'1M0&O1_;(KJ/4!J!E\R+3=[>5SC-T6
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M=RKP0N<$]14FEV]Y>?$QKRYCB1[#1TM[@P9\OSI'W%5)Y( 7/XBA =U10**
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M-(2]PZ '<QC'(&>@ZU8NKRXOM2TWQ!;:3J9BLS)#-;S6QCEVN/OJC<MCVYH
MUXO%5DT,[SV]Y:R6[JL\,\0#QANC'!(*^X)K=4@C(((/<5R&IZI=ZAX=UN2?
M3I;2Q\@I;FX4K+(Q&,E/X1G&,\UT>DI+%I%E'-GS5@0/GUVC- %VC%%% !11
M10 5EZIX>TS69$DOK;S)$4H'61T)4]5)4C*^QXK4HH CAACMX4ABC5(T 554
M8  ["I*** #%%%% !BBBB@ HHHH **** "LW6/\ CW3_ 'JTJS=8_P"/=/\
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M_"_X4:!^\[+[_P#@%O[7;?\ /Q%_WV*/M=O_ ,_$7_?8JI_PC^C_ /0+LO\
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M@59?]^%_PHT"]7LOO_X!;^UV_P#S\1?]]BC[7;_\_$7_ 'V*J?\ "/Z/_P!
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M>;%_SUC_ .^Q5;^R=-_Y\+7_ +]"C^R=-_Y\+7_OT*>@?O/(L^;%_P ]8_\
MOL4>;%_SUC_[[%5O[)TW_GPM?^_0H_LG3?\ GPM?^_0HT#]YY%GS8O\ GK'_
M -]BCSHO^>L?_?8JM_9.F_\ /A:_]^A1_9.G?\^%K_WZ%+0/WGD7[J:(W4A$
ML?7^^/2H?-B_YZQ_]]BH[G2--6YD T^U !Z")?2HO[)T[_GPM?\ OT*-!R]I
M=[%GS8O^>L?_ 'V*/.B_YZQ_]]BJW]DZ;_SX6O\ WZ%']DZ=_P ^%K_WZ%&@
MKS\BSYT7_/6/_OL4>=%_SUC_ .^Q5K2=$TJ3S=^FVC8QC,*G^E:?]@:/_P!
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M\X****!A1110 4444 3-_P >D7^\W]*AJ9O^/2+_ 'F_I4- Y!1110(****
M"BBB@ J:?I#_ -<A_6H:FGZ0_P#7(?UH&MF0T444""BBB@ HHHH **** )KK
M_CZD^O\ 2H:FNO\ CZD^O]*AH'+=A11102:VB_\ +;\/ZUJUE:+_ ,MOP_K6
MK6<MST*/P(****1J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!YQX?\0Z?I^M^)]5UBX$$ESKXTF)V4E5$<:B-2?X0<L<G
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M )F/_9>J?]!^X_\  >+_ .)H_LO5/^@_<?\ @/%_\36Q11=A[*/G][_S,?\
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M^Q7O_06E_P"_$?\ A5^BBX>SC_390^Q7O_06E_[\1_X4?8KW_H+2_P#?B/\
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M7RS6$>I7UO/9Z;&T5JD4)5W!4H#(22.%...O6@1>N_%VG6DS1!;BX<)$R"!
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M_P!"_-_X%1?XT68>UCY_<_\ (V:*QO[4U;_H7YO_  *B_P :/[4U;_H7YO\
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MG%%8W]J:M_T+\W_@5%_C1_:FK?\ 0OS?^!47^-%@]K'S^Y_Y&S16-_:FK?\
M0OS?^!47^-']J:M_T+\W_@5%_C19A[6/G]S_ ,C9HK&_M35O^A?F_P# J+_&
MC^U-6_Z%^;_P*B_QHLP]K'S^Y_Y&S16-_:FK?]"_-_X%1?XT?VIJW_0OS?\
M@5%_C19A[6/G]S_R-FBL;^U-6_Z%^;_P*B_QH_M35O\ H7YO_ J+_&BS#VL?
M/[G_ )&S16-_:FK?]"_-_P"!47^-']J:M_T+\W_@5%_C19A[6/G]S_R-FBL;
M^U-6_P"A?F_\"HO\:/[4U;_H7YO_  *B_P :+,/:Q\_N?^1LUFZQ_P >Z?[U
M0?VIJW_0OS?^!47^-4=2U'4WA02:',@W=?M,7^--)W,ZM6/(]_N9'15#[;??
M] B7_P "(_\ &C[;??\ 0(E_\"(_\:TLSS_:1_I,OT50^VWW_0(E_P# B/\
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M;2^L;32]*;4I;R%IE*W*1*$&.<MUSD5%'XTMS8NTMC=1ZBEP+0Z>=ID,I&0
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MFB#<-Y3.-V/3-%UV#DG_ #?D4/[<G_Z >I_]\)_\51_;D_\ T ]3_P"^$_\
MBJT;>[M[KS/L\T<OEN8WV'.UAU!]^14WX4778.2?\WY&1_;D_P#T ]3_ .^$
M_P#BJ/[<G_Z >I_]\)_\56O5>XO[.TFMX;BXBBDN'V0J[ &1L9POJ:+KL')+
M^;\BA_;D_P#T ]3_ .^$_P#BJ/[<G_Z >I_]\)_\56BEW;O<R6RRH9XU#/&#
M\R@]"1[X-3?A1==@Y)_S?D9']N3_ /0#U/\ [X3_ .*H_MR?_H!ZG_WPG_Q5
M:-Q=VUH(S<31Q>8X1-YQN8] />G6]Q#=0+-!(LD39PZG(/:BZ[!R3_F_(S/[
M<G_Z >I_]\)_\51_;D__ $ ]3_[X3_XJM*"ZM[EI5@E20Q/Y<@4YVMUP?0\B
MIJ+KL')/^;\C'_MR?_H!ZG_WPG_Q5']N3_\ 0#U/_OA/_BJV**+KL')/^;\C
M'_MR?_H!ZG_WPG_Q5']N3_\ 0#U/_OA/_BJV**+KL')/^;\C'_MR?_H!ZG_W
MPG_Q57+*^>\W;[&YMMO_ #W51GZ8)JYBDHNBE&2>LBM>W;VD0=+2>Y).-L(!
M(]^2*H_VY/\ ] /4_P#OA/\ XNM2:>*!-\TB1KD#+L ,GZT&>%9EA,B"5@2J
M%AN('4@4702C)O1V,O\ MR;_ * >J?\ ?"?_ !5']N3?] /4_P#OA/\ XJM?
MBF2311;?,=%W':NY@,GT%%UV)Y)_S?D9?]N3_P#0$U3_ +X3_P"*H_MR;_H"
M:I_WPG_Q5:2W,#2"-98RY&0H89(]<5+Q1==@Y)_S?D9']N3?] 35/^^$_P#B
MJ/[<G_Z FJ?]\)_\56OQ1D4778.2?\WY&1_;D_\ T ]3_P"^$_\ BJ/[<G_Z
M >I_]\)_\56HDT3NZ(Z,R'#*&!*_7TI_'M1==@Y)_P WY&1_;D__ $ ]3_[X
M3_XJC^W)_P#H!ZG_ -\)_P#%5JF1 X3*[B,@9YIW%%UV#DG_ #?D9']N3_\
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M *!.I?\ ?M/_ (JC_A*%_P"@3J7_ '[3_P"*JG119=B_:U?YOP+G_"4+_P!
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MH7_H$ZE_W[3_ .*JG119=A>UJ_S?@:$?B)IL^7HVIMCKB-/_ (JG_P!N3_\
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M:Z2W\8:.^IQZ/+?Q'4]_D.L:.8O."[FC60KM+#KMSGVI\S,O8P_ILM?V+/\
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M_OJ+_P"(K7HHYF'L8?TV9']B7'_0<U3_ +ZB_P#B*/[$N/\ H.:I_P!]1?\
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M+"_2"XTR]2V:=;<7;!%0NV,84MO9<D#<!C\J@M?&]O<2QF33+Z"UEDEACN9
MA5GCW;A@,6_A.#CFJ%UX DN=4ENOM]L0]XEV))+(/.-I!\OS"W"<<8 ZUI1>
M%&CM-/A6^(:SNIK@.(^3O+G R>,;^O/2@"O%X^LVTF;4Y+"\CM517BES&R2A
MB !N5BJGD9#$8[]ZG?QE%';0;],O%O)Y#'':LT8+X&XL'+;"N.X/MUJC;>![
MJ":ZN1J-G%=30^27M].5$F^8$M,FXB0G&#C'4XJNOPXC2-)5FT\727#3+$;
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MW')SD#(].:Z;[;KG_0'M_P#P-_\ L*/MNN?] :W_ / W_P"PHY6'MEV?W/\
MR.8@^$/A*VOKZ>WL?)CN[0VIA1B!&#G<RDDG<0?T%6['X>VUII&KVDFJZA=7
M.J6XMIKR=E,BQJI557  & 3VY)K<^VZY_P! >W_\#?\ ["C[;KG_ $![?_P-
M_P#L*.5A[:/9_<_\BKJGA2'4-#L=-AO[VP:P\LVUQ:2!'0HNT9'1ACJ",5D/
M\,]/%A:):ZGJ5MJ%M-+/_:,<BF:1Y1B0MD8.X8[<8%=#]MUS_H#V_P#X&_\
MV%'VW7/^@/;_ /@;_P#84<K#VT>S^Y_Y',:E\(/">HZ-#8-9%)8(%@BN]Q,J
MJ"3]"22>W>KVC^&38^-)+V.U%MIUCIL=A9+NSNRVYR.20!A1S[UL_;=<_P"@
M/;_^!O\ ]A1]MUS_ * ]O_X&_P#V%%F'M8]G]S_R->BLC[;KG_0'M_\ P-_^
MPH^VZY_T![?_ ,#?_L*.4/;1[/[G_D:]%9'VW7/^@/;_ /@;_P#84?;=<_Z
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M7/\ H#V__@;_ /84<H>VCV?W/_(UZ*R/MNN?] >W_P# W_["C[;KG_0'M_\
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M0^T:I_T#H/\ P*_^QH^T:I_T#X/_  *_^QK2QP>T79_<R_15#[1JG_0/@_\
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MVW7/^@/;_P#@;_\ 84?;=<_Z ]O_ .!O_P!A1RA[:/9_<_\ (UZ*R/MNN?\
M0'M__ W_ .PH^VZY_P! >W_\#?\ ["CE#VT>S^Y_Y&O161]MUS_H#V__ (&_
M_84?;=<_Z ]O_P"!O_V%'*'MH]G]S_R->BJ%G<ZE+*5N["*!,<,EQO.?IM%7
MZ1<9*2N@HHHH*,_4=9LM*GL(;N1D>^N!;0 (6W2$$X..G /)K)7Q[X=?1=1U
M=+XM::=/]GNB(FW1ON"XVXR>2.17+:CJFJ>)?%FA:9+X?OK.YTO66N)I"C-
M8%1@L@EP =VX<=:X+5?#&LV7@W4+_3M.N6.HW\]KJ-L(VW,HN=\,P7&3C!7/
M<,/2A:@>]ZKK5CHL=J]](T:W-S':Q80MF1SA1QT^M)K6NZ=X>TYK_4[@0P*P
M0':69F)P%50"6)]!7!^)]1U+7M>T_P /_P!@WT,UGKEO<+<"-F@DMD.XRF3
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "C%%% !BC%%% !BBBB@
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M!L49K'_X1G3/[MU_X&3?_%5<L=,MM/W_ &<2C?U\R9Y/_0B<4.PXN=]5^/\
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M5.R^_P#X!KXHK(_X1G3/[MU_X&3?_%4?\(SIG]VZ_P# R;_XJBR#FJ=E]_\
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M_+S)[?[51?V+8_W9O_ F3_XJEH5)S[?C_P  T<'T/Y48/H?RK._L6Q_NS?\
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MW;K_ ,#)O_BJ- YJG9??_P  V**Q_P#A&=,_NW7_ (&3?_%4?\(SIG]VZ_\
M R;_ .*HT#FJ=E]__ -BBL?_ (1G3/[MU_X&3?\ Q5'_  C.F?W;K_P,F_\
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MNNP<D_YOP,;^WI/^@+JO_?E?_BJ/[>D_Z NJ_P#?E?\ XJMG HP*+KL')/\
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M.S[WDRJ^/K@\4)H<HR;T=BE_;TG_ $!=5_[\K_\ %4?V\_\ T!-5_P"_*_\
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M\K_\51_;TG_0%U7_ +\K_P#%5LX%&!1==@Y)_P WX&-_;TG_ $!=5_[\K_\
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M4- Y!1110(FM/^/R'_?%=(*YNT_X_(?]\5T@J)'7AOA8M%)FC-2=(M%)FC-
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M/L8__"/I_P!!+5/_  +:C_A'T_Z"6J?^!;5L44<S#V-/L8__  CZ?]!+5/\
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M&?*BN+!+D/,229F#,!NYXXX[5U__  D5K_SZZC_X R__ !-'_"16O_/MJ/\
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M ,O_ ,31RL/;4^YKT5D?\)%:_P#/MJ/_ ( R_P#Q-'_"16O_ #[:C_X R_\
MQ-'*P]O3[FO161_PD5K_ ,^VH_\ @#+_ /$T?\)%:_\ /MJ/_@#+_P#$T<K#
MV]/N:]%9'_"16O\ S[:C_P" ,O\ \31_PD5K_P ^VH_^ ,O_ ,31RL/;T^YK
MURWB/0-8UF:2W@U2"/2[E%2>&6 LZ8.28R".2.#NST%:7_"16O\ S[:C_P"
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MY]M1_P# &7_XFC_A(K7_ )]M1_\  &7_ .)HY6'MZ?<UZ*R/^$BM?^?;4?\
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MF/3%4+;P=JNFV[)8:C:!KB V]SYT+, ,G#)@CG!Q@\5T7_"16O\ SZZC_P"
M,O\ \31_PD5K_P ^NH_^ ,O_ ,31RL/;T_YC*M?"4UCIVI6EO=0$7*QK'Y\
MD7"K@AU/!!]JL^%/#TN@172R/;HL\@=;6U#K!#@8P@8DC/4XP/:K?_"16O\
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M"O\ X4?VO!_SPO?_  %?_"BS#VL.Y?HJA_:\'_/"]_\  5_\*/[7@_YX7O\
MX"O_ (468>UAW-5O^/2+_>;^E0U5;6+<VT8\B]X9O^723V]JB_M>#_GA>_\
M@*_^%'*QRJP[E^BJ']KP?\\+W_P%?_"C^UX/^>%[_P" K_X468O:P[FK:?\
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M2*U_Y]M1_P# &7_XFCE8>WI]S7HK(_X2*U_Y]M1_\ 9?_B:/^$BM?^?;4?\
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M,P52S$ #DDGI7CDWQ#\0VOP_T_Q MS;7%\E_-:/9^4#]M52P!!3."H&XE>"
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M\K_#_,V,UFZCX=T35YDFU/2+"]D085[FV20J/0%@<5#_ &=K/_0=_P#)-/\
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M[6?^@[_Y)I_C1;S#GE_*_P /\S9S1FL;^SM9_P"@[_Y)I_C1_9VL_P#0=_\
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MFC"S9 \L^C<CBN.@L_&.@^)_$-SINAV%]::E=K<))+J'DLH$:KC;L/I6;?\
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M^^*Z05S=I_Q^0_[XKI!42.O#;,6BBBI.D**** "BBB@ HHHH **** "BBB@
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M>B?]!>Q_\"%_QH_X2/1/^@O8_P#@0O\ C5>BCE0>VJ>7W?\ !+'_  D>B?\
M07L?_ A?\:/^$CT3_H+V/_@0O^-5Z*.5![:IY?=_P2Q_PD>B?]!>Q_\  A?\
M:/\ A(]$_P"@O8_^!"_XU7HHY4'MJGE]W_!+'_"1Z)_T%['_ ,"%_P :/^$C
MT3_H+V/_ ($+_C5>BCE0>VJ>7W?\$L?\)'HG_07L?_ A?\:/^$CT3_H+V/\
MX$+_ (U7HHY4'MJGE]W_  2Q_P )'HG_ $%['_P(7_&C_A(]$_Z"]C_X$+_C
M5>BCE0>VJ>7W?\$L?\)'HG_07L?_  (7_&C_ (2/1/\ H+V/_@0O^-5Z*.5!
M[:IY?=_P2Q_PD>B?]!>Q_P# A?\ &C_A(]$_Z"]C_P"!"_XU7HHY4'MJGE]W
M_!+'_"1Z)_T%['_P(7_&C_A(]$_Z"]C_ .!"_P"-5Z*.5![:IY?=_P $L?\
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M:IY?=_P2Q_PD>B?]!>Q_\"%_QH_X2/1/^@O8_P#@0O\ C5>BCE0>VJ>7W?\
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M_P"!"_XT?\)'HG_07L?_  (7_&J]%'*@]M4\ON_X)8_X2/1/^@O8_P#@0O\
MC1_PD>B?]!>Q_P# A?\ &J]%'*@]M4\ON_X)8_X2/1/^@O8_^!"_XT?\)'HG
M_07L?_ A?\:KT4<J#VU3R^[_ ()?M=7TV^E,=I?VT\@&2L4JL<?0&KM9MC_K
3_P *TJAZ,Z*<G*-V%%%%(T/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tmb-20210505xex99d1011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ *(# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WQ1TS3N]
MZ4M) )BC%+13 3%&*6J>IZE;Z3I\U[=.$BC7)SW]J +>*,54TR>[N-/AFO85
M@GD7<T0S\F?X3[BIXYXY7D2-PQC.UL=CZ4 28HQ14-U<I:6TEQ(<(BY- "^=
M']I\C/[S9OQ[9Q4N*RM%2ZE634+V)H9[C!$)_P"6:#H/KC!/O6K0 8HQ11F@
M Q1BC-&1ZB@ IN>>AIV:,T &,T8I:#0 F**9N/K12 >.@I:0=!2YH0!1165J
M>OV&EL(I9O,NF&8[6/YI7^BCDTP+EY>PV4/F2GJ=JH.KGL *P3I3ZYJ4%UJ*
MYAMGWI#G*JPZ?4^O_P!:JHEU?4;T2Q6$:714%7NB=EJI[; 0=Q'?^E:,FFZO
M%92/%?GSPOR6T*JL9/U8$C/UI#+FI:BT+BTM0&NG7=D_=B7N[?3T[_K6?IFI
M0P7EMIUG;S2I-O>2[;A788R?7O2:'X>GBLD;5G\RY?#2JKD@M[G//TZ>U7++
M][XBOFC4?9X88X5P.%D!8L!^!6@#8K'N#_:FK+: YMK4B28_WG_A7\.21[BM
M&\F:WL;B=%+O'$SJOJ0,XK"TW6]+M[)5AG-U/(?,E%NOF,7/7('?H/PIB.DJ
M&Z-P+:0VJQO/CY%D8JI/N0#6;_;-W, ;/1[J0?\ 3?\ <'\F%!;Q#-\T::?;
M@_P2AG(_%2!2 BG_ +4; E^T;<#*VJJ#GO\ ,6'\J:MO(R@%-:&/6=>?UJ;^
MR]5E?S)=;FB/>.")-O\ X\I/ZTHT RY%[J5Y=+Z%Q'_Z !0 QH8< 2:7>2D?
MQ.5)_P#0J:D5F3_R!YU]SL_^*J=/#6FQ@A5N>?6[E/\ -J0>&=+!SY<__@5)
M_P#%4 .6"V;G['(OU*_XU)^YA^9;-V*],%?\:9_PCVG ?ZN;_P ")/\ XJFG
MPUIC')CF_P# F3_XJ@"XE\6&3:S)]=O]#2K?P,!O;R\_WQC]:HGPSIA+'R[@
M%EVG%U*./^^JB?PCH[Q&.2&X="<X:[E//XM0!K[AZ441(L,21)D(BA5R<G ]
MS10,E'2JE[J$5F -DDLK?=BB&68_R_.DN;Y;>0194':7=V.%11W-9]O/<7[R
M&QC,,).&NY!\T@_V!Z>_2@17N)-0U&;R/,\M@>8(&X ]7?M_N@'FK.E>&[+1
MUFFMH8OMTPR\Y7DGL/H*T[*RAL83'"O4[F8\EB>I)JS0!G:-9W%EI\:WLJS7
MKC=<2J,!G/7 [#T%:-%)3 KW]TME8S7#?P*2!ZGL/Q/%0:/:FUTV,.<RO^\D
M8]23SS^&!^%5=4C?4-3M-/60I"A^TSCCYPI^5?;YMI_"MD=*0!VYIHC13\J*
M/H*?13 2EHHH **** "BBB@ HHHH **** &;313Z*0%"72;.>\^U31;Y,# 8
M\#'?%7E     'H*6BF 4444 %-=@BEF. !DTZLO6G>2&.PA.);IMF1U51]YO
MPR* &:&3<I/J;=+M]T?_ %S'"'\1C-:],BB2&)8XU"HHPJ@< 4^@ HHHH **
M** "BBB@ HHHH **** "BBB@!-U%)10 ZBBB@ HHHH *R%&[Q5,6).RU0J#V
JRS9_D*** ->BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tmb-20210505xex99d1017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !& )$# 2(  A$! Q$!_\0
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)10 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tmb-20210505xex99d1015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Q .L# 2(  A$! Q$!_\0
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/ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tmb-20210505xex99d1020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1020.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  T .<# 2(  A$! Q$!_\0
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M;7B!+F".50<@.H.#ZCTII@/6&) H6-%"_=PH&*:]K!)('>&-G'&YE!-2(@1
MJ\ =*=2NP&@ <"EQ5:TCNTDN?M,L;HTI,&U<%4P.&]3G/X8JU0 T(%'  YSQ
M2XI:* "BBB@ HHHH **** "@]*** &K&B;MJ@;CDX[FG444 %%%% !1110 4
J444 %%%% !1110 4444 %%%% !1110 8HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tmb-20210505xex99d1013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !; )T# 2(  A$! Q$!_\0
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MTA]SBG!& 'SDT 244W!_O4G[P'JI'TH ?132Q'\.:<* "BBB@ HHHH ****
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7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tmb-20210505xex99d1021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1021.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  K /(# 2(  A$! Q$!_\0
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MCC141>BJ, 4^BE>X6# I, #BEHH&%%%% !1110 4444 %%%% !1110 4444
3%%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tmb-20210505xex99d1012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !! *4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MI"0!DG H 6BJ;:E$2RP*]PX."(ER!^)X_6F[M2E8X2W@3L6)=OR&!^M %ZBL
M[['J)8DZH1[+;J /SS3]UY: -)(MS'G#$)M91Z\<']* +U% YHH ***BFN(8
M!F614^IH EHJI]KDD.(+:1Q_??Y%_7G]*:8+V8@R72PKW6%,G_OIO\* +C,J
M*69@ .Y.*K-J%MG;&YE;TB4O_*HTTJT5P\B-.XZ-.Y<_KP*D:\MXSY:'>X'^
MKB&X_IT_&@!B75W,#Y=DT?H9W"Y_ 9-0S"[2/S;K48;:,==D8'_CS$_RJ<&\
MGS\J6R'IGYG_ ,!^M.33[<2"613-*O1Y3N(^GI^% &284O@/(CNKQ6'^MN)6
M2+\N,_@*6#PI8"YCN;J&"66)P\2I$$2,CH1W)]R:W\44 %%%% !2$A1DG %+
M5'4K*:[$+0W'E/%('VLNY']F'I0 \W,LQQ:QAAWDD.%_#N:!9"3FZD:<_P!T
M\)_WS_CFJPU.6U;;J-JT*]//C.^(_4]5_$5I(ZR('1@RD9!!R#0 JJ$4*H
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MJYH5E:QVWFI9F*0,5#R#+,!T.3ZUL$JH+,0 .23VH R[;0;.':TJ_:)%Z-(
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AHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tmb-20210505xex99d1019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !" (X# 2(  A$! Q$!_\0
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tmb-20210505xex99d1005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %[ Z@# 2(  A$! Q$!_\0
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MHHH **** "BBB@ HHHH **** "BBB@!,4M%% !BBBB@ HHHH **** "BBB@
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M $(JEIVDV6E),EE (5FE::0!B=SL<D\FKU% !1BBB@ HQ110 4444 &****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=Z77_@9+_P#%4:!>IV7W_P# -:BLG_A'-.]+K_P,E_\ BJ3_ (1S3O2Z_P#
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M96OR_C_P#M*,5Q7]G0_W[K_P*D_^*H_LZ'^_=?\ @5)_\51R+N'UJ7\OX_\
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MS<E)PZS*;BYDE<;>%/))"C\JNP^'M%FNO[1BB,HE)E4"=FA)88+A,[<D=\4
M9VB:KJU[XFC6]\J.WFTT7$<4+DJ"6&,Y[@'K77"L72_#.EZ/>O=V<,JS-'Y6
MZ2=W"IG(4!B0!GL*V<_6F M%-=U1"S'"@9)/85';7$-W;I/!(LD3C*NO((H
MFHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ KF[W_C\E_WJZ2N;O/\ C\E_WJJ.YS8G9$%%%%6<@4444 %%%% !4MS_
M *]JBJ6Y_P!>U ^A%1110(**** "BBB@ '45+<_\?,GUJ,=14ES_ ,?,GUH'
MT(J***!!1110 4444 *OWU^HITW^O?\ WC35^^OU%.F_U\G^\:.H_LC****!
M!1110 4444 .3_6+]12R_P"N?_>-)'_K%^HI9?\ 72?[QH'T&4444""BBB@
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M9@CH,QQLXD)R<#Y<$8/UIAN:FN^%$U_Q'I%]??9Y]/L%F+6DT6\22.  3GC
M&:S=4^'5GK&KQRSS-::;:0%+*TTYVMO+=B?,<E,9R,# [9]:H77B76KN,VHD
MCCFW64\,QMY+=2'F"E2&8LR^_&>F*ZBQUBY^RZN+Y[7SM-D96F4%(F&P."1R
M5P#@]>E '/?\(5K]MX9TW1[/6;"2&V@:WGM[ZQ$\,J[B5;&0P8#CK@TEC\+[
M%+G3(]7:#5M/T[3S:PPW4.[]XS[F?!X Q@ =A2?\)GK0W1+';/,Z6TD4DEK)
M"F)90AX9MS  Y!X^E:$/B#6+C4AI :Q6Z6>='N#$VQDC5&&$W9#'S .O&":
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M0 4444 *OWA]13IO]?)_O&FK]X?44Z;_ %\G^\:.H_LC****!!1110 4444
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MQ]O?V%!TRT(P8>/]X_X^] >\6<#THP/2JITNS.<P]>OS'W]_<T?V79YSY/\
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MG6G_ #R_\>/^-)_9EG_SQ_\ 'C_C1H'O%O-&:J?V79_\\?\ QX_XT#3+0?\
M+'_QX_XT:![W8MT9JK_9MI_SR_\ 'C_C1_9UK_SR_P#'C_C1H%Y%G-+FJO\
M9EI_SQ_\>/\ C2?V79_\\?\ QX_XT:!>78MYHS53^R[/_GC_ ./'_&E_LVT_
MYY?^/'_&C0/>+5&:K?V=:_\ /+_QX_XTG]FVG_/+_P >/^-&@>\6LT9JI_9=
MG_SQ_P#'C_C1_9=G_P \?_'C_C1H'O=BWFN<O?\ C\E_WJV?[-M!_P L?_'C
M_C6!>6=N+N4"/^+U-7'<Y\0Y<J$H_.H/L=O_ ,\_U-'V*WS_ *O]35Z''[Q/
M15?[%;?\\_\ QXTOV*W_ .>?ZG_&@/>)Z*A^R0?\\_U-'V2#_GG^IHT#WB:I
M;G_7M5/[%;_\\Q^9J2XL+83,!%Q_O'_&D/WK#Z.?2H/L5O\ \\OU-+]D@_YY
M_J:>@M2:C\*A^R0?\\_U-)]CM_\ GG^IH#WB>BJ_V&V_YY_^/'_&C[%;?\\Q
M^9_SWH#4L#J*EN?^/F3ZU4%G 3_J^_J:DN+. 7#CR^_J:!ZV'45!]CM_^>8_
M,_Y[4GV*W_YY?^/&@5Y%CFBJ_P!BM_\ GG^I_P ]S2_8[?\ YYC\S1H%Y$]%
M0_9(,Y\O]32?8X/^>?ZG_/84:!=EA?OCZBG3?Z]_]XU56RML@>5W'\1_QI\]
ME;^?)^['WCW/O[^YHT'=\I)^%%0?8[?KY?ZFE%I /^6?ZG_/:C07O$U'X5!]
MC@QCR_U/M_@*/L5N>/+'YFC0/>)_PH_"JYLK?G]V.?\ :/O_ (FE^Q6__//_
M ,>-&@7D64_UB_44LW^N?_>-5X[. 2)^[Z,.Y]1_@*66SMQ*X\O@$XY/^>PI
M#UL2?G14!L[<@_N_U/\ GO2&RMSG]WU_VC[_ .)IZ"NRQ1^%0?8K?/\ J_U-
M LX!C$?3W/M_@*- ]XG_  HJ#['!_P \_P!30;.W(P8^/J??_$T![Q:A_P!?
M'_O#^=)+_K7_ -X_SJ"*RMFG0&+(+#/S'U_^N:'LK<2MB(?>/\1]:-!^]RDO
MX4?G4 L[=>D?3W/M_@*/L=OC'E_J:-!7D3\T?A4!LX#UC_4^_P#B:#96Y/,8
M_,^_^)HT#WB>BH/L5OG/E\_4_P">U LK<8Q'C'N?;_ 4:!>19C_UB?[P_G14
M$=G;[T'ECJ.YHJ6:T[V,FY%^FD>(/$$>MZA%=6%Y<F*-I]UN5C;A#&1C! QZ
M\YK3F\97,7B""S$5N\$MXMHRQK(SQ%D+99\; <C&S.?Y5I-X*T22^DNI()Y/
M,G^T-"]U*83)G.XQ;MF<\].M3-X3T=M0^VFWD\T7'VI1Y[[%E[N$SM#'N<<\
M^M9'HG.2>,]6BT:QNY(M.2XN[9[I85$TK;0 0NQ 6[\OP![T:7XKU*?69Y)/
M+:SN9K!(83G,(FBWMSW-=%/X1T:XBMHWMG5;> VR^7.Z;H3C*-M(W+P.#33X
M/T;RRBVTB QPQY2=U(\K_5L"#D,HXW#G%,#'NO%NJ^?/%96EF3";TLTS-C;
M4 &!W;=^&*=:>+M1>6S2YM+53=_8Y$$;L=D<Y88.>K#;U'!S6W;^%M(M(RD-
MJ54K,IS(Q)$I!DR2<DD@'-+-X7TF> 0O;,%6**%&65E9%B),>U@<@@GJ.: ,
M.Z\5:LUU/;V-I9EH3=EFF=L8A*8''<[OPQ4?_"9ZA%:EKJ&PADE@MKB$EW*J
MLQ(VD ;G88X"CG/:N@M?#&DV:E8+8KE95),C,3YA!?))R22!S3;CPII%RL8>
MV=6BCBCB>.9T>,1YV;6!R",GGWI <Q:^(]=U?5+#[$MO&X6]CGCF$B1L8FC
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M+G_CYD^M ^A%1110(**** "BBB@!5^\/J*=-_KW_ -XTU?O#ZBG3?Z^3_>-
M_LC****!!1110 4444 .C_UB_44LO^N?_>-)'_K%^HI9?]<_^\:!]!E%%% @
MHHHH **** 'P_P"OC_WA_.DD_P!:_P#O'^=+#_KX_P#>'\Z23_6O_O'^= ^@
MVBBB@04444 %%%% #H_]8G^\/YT41_ZQ/]X?SHI,UI['4T445F=X4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5YIWB8 02R
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M2\&@+/N5/MDG_/E<_DO^-+]KDQ_QYW'Y+_C5K HP* L^Y5^UR?\ /I<?DO\
MC1]LD_Y\[C\E_P :M8%&!0%GW*GVV3_GRN?R7_&C[;)_SY7/Y+_C5O HQ0%G
MW*OVQR/^/.X_)?\ &N?O+AOM<I^SS?>]!_C758KG+S_C\E_WJN.YSXA/E6I1
M\]O^?>;\A_C1]H?/_'M-^0_QJ?%&*LX[/N5_M#_\^T_Y#_&E^T/_ ,^TWY#_
M !J?%% 6?<A\]O\ GWE_(?XTGGMG_CWF_(?XU/BC% 6?<@^T/_S[3?D/\:DN
M+ES,Q^RSCIQ@?XT_%2W/^O:D59VW*?VA_P#GVF_(?XT>>W_/O-^0_P :GQ1B
MF39]R'SV_P"?>7\A_C2?:'_Y]IOR'^-3XHQ0%GW*_P!I?_GVG_(?XTOVA_\
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M% 3\G3+ @5D0:S>&Y%S/>_8S<B!+B\VJ"J9;#<C"YP.2,<UZ1+;03J%EACD
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MPB@D02C4HE&2K+$7!7V/!'Y4<S#V4?Z;.G_LJZ_Z#5_^47_Q%']E77_0:O\
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M4?Z;,K^RKK_H-7_Y1?\ Q%']E77_ $&K_P#*+_XBM6BCF8>RC_39E?V5=?\
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M>?(2D^22@90 >B\=M^*]%0ED4D8)'(]* '4444 %%%% !1110 4444 %%%%
M!1110!BZEH)N]0&H6=_<V%X8_*DD@"-YB9R 58$<<X/49K/D\'/%/;RZ;K>H
M6+Q0M"[JL<K2AFW$L74\YYR,5U5% '(7'@8%K V.L7MI]B+NO[N*;?(QRTC>
M8I^?KSVSQ5R7PG%<78EFO[IXY#&]U#A MPZ?=9L#(Z<A< XKHZ*  4444 %%
M%% %34[%-2TVXLI'9$GC*,R]0#Z5@W?A'1]3UB"]DD9I[>V:VDC1QB1&7;\X
M]1G@^]:OB+[5_P (_?\ V+=]I\AO+V?>SCM[UQ9U'1+*72?['T^RN)MH$<MO
M<A9U<J<AT W,/7<: .BC\(0&WN4N[^[NY)K?[*DLNT-%$.@7: ,\#D\G J"?
MP-:2K;+'?W4/E6IM791&S2*>2<LIVL3R2N.M<S;>(];FTZ25=8B\U[97=1-'
M*\$A=1PH0;1R1AB35^34=7_MM](76;D1QWIC\[;'YA3R6?:3MQU'I0!T(\*6
MZZ=/:)=W"F5HG$@"DJT8 ! QCMWJM<>#()[06C:I=K!([M-$5C99=S;CPRG!
MST(YKG8?$>IVND07=UJ\\GVFSD=F$<7R,L@0%> !QU+''>JRZS)>7ULE]KOV
M>*WU'8ET9HI&4-$QV[PH7\<?C0!W>J:0TLNF3VHR]E)@ GDQE=K#)]C5<^%(
MX[2TBM-0NK6:U#JD\80L5<DLI# COZ<50.MZ@O@9[];C,HD*"[,8.8M^/-QC
M'3GICO6;_:^H7&KPZ=9:]+/8M=K&+U!&S.#&Q9 P7:<$ Y XS0!JIX6"^(M/
M9('2PT^V91*TP)G=CW YR#DY/<\5'%\/;../RO[1NS$J2QQIMC&U9.N2%!8^
MYR:)]6U!?A_<WBWI%Y$7C6YVKGA]H)&,9Q[5D:EKNLZ=?R:<-2=[<72(]W,\
M<31JR%L;RNT9(X)% '2_\(?9M<R-)<SR12,7,)V@9,>P\@9Z8_&EA\+RP6DD
M(UW4-VU5B?$8\M5Z#:%PWON!S6%X=NKJ[\5V-Q?:@LDCV$JH(I0T<H$@P?NC
M)QUQQQ3-2UVZ^WR(VMF"Y_M 6XT["?-#CK@C=SR=V:0'36GAJSM_#L^D)-(T
M5QO,DHV@EFZD #:/H!BJD7@ZW\Q0^I74ML9%EFM_D"2RJ  QP,CH,@$ XKE[
M;6[JTTPHNK?8WMK6-[.V 3_2F+'/4$MV&!ZT[2]8EL7=X=58SO?RB?3U5&\M
M-H+-MQNR.N<X[4P/3BRJ,E@/J:=7DO\ ;]SJ.;>34&N8'CAG DFB=E;S .D8
MPG!^Z2<5ZR* &RS1PKNED1%]68 4D<T<J;XW5U]5((KE/&UO+=7.APPBT:1K
MSY1=Q&2/[IZJ",_G7*QZA?:*;J /;V5[-J"1WJVX6"&"/:=KH6W!0W]XCK0!
MZOO&[;N&[&<9I<^]>4OKUU!*NH75\C2I9RHES;%925\Q0#DA5SV+=*=;>*+V
M6]2TN/$!M;47QB:X\V&1MACW!2X7;U[XH ]4S2*ZL,JP(Z<&O,'\4:L@M)IM
M57RP.(XVC264;\"38Z_O 1V4@U:BU'4[F:6.'4Y+6..&XGVPQQ@LROQG*G\:
M /1LT9KS:?Q)>N!+)KAM+L36Z1V:K'B5& RVTC<<\\@\5K^*+W48]9%O::G+
M:1)I\EP5C5#N=3QG<#Q2 [+/O2%U!P6 /7&:\^37=0L+V!+K5F>W?[-++).$
M4(''S#(  7_.:Q+W4I-9^UW+:@^U8IE2>,JN$65<<XQCWI@>MK(K9PP.#@X/
M2E#J6(##(ZC/2O,1KDL>IK;/X@%C:/-<?OE$0\S:H*_,5P3_ #JH->U5+E[H
MLL$UT+9+F<LL6Q,'#98$+G Y([T"/6LT9KDM.U34)O!EW=RZA:>?&7$5V'WI
MM!X+,% )]2!BN>L_$UY.T5I<ZS+;6_GE9K[?#(J_)E564#:03Z@$=*!GIN\$
MD!AD=12Y]Z\LEUJ\M[J>6UOR\=S-!'->L%@.W8<'+ JN?4C%7+76=<N&W?VF
M)?(LI)U6V*R+,0V%+-M&>.NW -%@/1\TF]=VW<-V,XSSBO-YM?O5B9++Q'%<
MH\$<DLTSQJ(G)Y0.%(3/;<#BJT?B2_N(Q)'J*0R+:L#/=+&.1)C_ %B@C&.
MP&.^* /3);NWAECBEN(HY)#A$9P"WT!ZU/7#Z))>^(+>%G83PV]PRS/*Z%VP
M<@+(@VNH]1C/M7;B@!:*** "N;O/^/R7_>KI*YN\_P"/R7_>JH[G-B=D0444
M59R!1110 4444 %2W/\ KVJ*I;G_ %[4#Z$5%%% @HHHH **** %'45)<_\
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MV6&.8RQE1'(Y16]MPY'UKAX] \31(L@B0H;C=Y;3Q&Z5=A7/G[,'G'^UCO2
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M]1WI1:6X0*(8PH79C8,;?3Z>U344 1Q0QP1K'$BHB\!5  'X"I*** "BBB@
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M2R&-$%O( 6&<C<5QV/>HNCLY9]S2_P"$A7_H%ZK_ . AH_X2%?\ H%ZK_P"
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M+X^M4_\ A(5_Z!>J_P#@(:V,48HT!J5]&8__  D*_P#0+U7_ ,!#1_PD*_\
M0+U7_P !#6QBC%&@<LNYC_\ "0K_ - O5?\ P$-'_"0K_P! O5?_  $-;&*,
M4:"Y9=S'_P"$A7_H%ZK_ . AH_X2%?\ H%ZK_P" AK8Q1BC0?++N8_\ PD*_
M] O5?_ 0T?\ "0K_ - O5?\ P$-;&!1BC0.67<Q_^$A7_H%ZK_X"&C_A(5_Z
M!>J_^ AK8Q1BC0.67<Q_^$A7_H%ZK_X"&C_A(5_Z!>J_^ AK8Q1BC0.67<Q_
M^$A7_H%ZK_X"&C_A(5_Z!>J_^ AK8Q1BC0.67<Q_^$A7_H%ZK_X"&C_A(5_Z
M!>J_^ AK8Q1BC0.67<Q_^$A7_H%ZK_X"&C_A(5_Z!>J_^ AK8Q1BC0.67<Q_
M^$A7_H%ZK_X"&C_A(5_Z!>J_^ AK8P*,"C07+/N8_P#PD*_] O5?_ 0UAW6K
M![F1OL&HC)Z&V/\ C7:8%<Y>_P#'Y+_O546CGQ$9<JU,G^U!_P ^.H?^ Q_Q
MH_M1?^?'4/\ P&/^-7Z*TNCCY9=RA_:@_P"?'4/_  &/^-']J+_SXZA_X#'_
M !J_12N@Y9=RA_:B_P#/CJ'_ (#'_&C^U%_Y\=0_\!C_ (U?HHN@Y9=RA_:J
M_P#/CJ'_ (#'_&I)]6#3,?L&HCZVQJW4MS_KVHNBN65MS+_M1?\ GQU#_P !
MC_C1_:B_\^.H?^ Q_P :OT471/++N4/[47_GQU#_ ,!C_C1_:B_\^.H?^ Q_
MQJ_13N@Y9=RA_:B_\^.H?^ Q_P :/[47_GQU#_P&/^-7Z*5T'++N4!JJY'^@
MZA_X#'_&I)]65IW/V#41D][8U;'45)<_\?,GUHNBN65MS,_M4?\ /CJ'_@,?
M\:/[47_GQU#_ ,!C_C5^BBZ)Y9=RA_:B_P#/CJ'_ (#'_&C^U%_Y\=0_\!C_
M (U?HIW0<LNY0_M1?^?'4/\ P&/^-']J+_SXZA_X#'_&K]%*Z#EEW*"ZJ-P_
MT'4.O_/L?\:=+JH,KG[!J R3_P NQ_QJ\H^=?J*=-_KW_P!XT717++EW,W^U
M!_SXZA_X#'_&C^U%_P"?'4/_  &/^-7Z*=T3RR[E#^U%_P"?'4/_  &/^-']
MJ+_SXZA_X#'_ !J_11=!RR[E#^U%_P"?'4/_  &/^-']JK_SXZA_X#'_ !J_
M12N@Y9=RBFJ@.O\ H.H=1_R['_&EEU53*Y^P:AU/_+L?\:OH/WB_44LO^N?_
M 'C1=%<LK;F;_:H_Y\=0_P# 8_XT?VHO_/CJ'_@,?\:OT4[HGEEW*']J+_SX
MZA_X#'_&C^U%_P"?'4/_  &/^-7Z*5T'++N4/[47_GQU#_P&/^-']J+_ ,^.
MH?\ @,?\:OT4[H.67<I1:J!,A^PZ@<,/^78^OUH?509&/V'4.I_Y=C_C6A#_
M *^/_>'\Z23_ %K_ .\?YTKHKEE;<SO[47_GQU#_ ,!C_C1_:B_\^.H?^ Q_
MQJ_13NB>67<H?VHO_/CJ'_@,?\:/[47_ )\=0_\  8_XU?HI70<LNY0_M1?^
M?'4/_ 8_XT?VHO\ SXZA_P" Q_QJ_11=!RR[E*+5 9HQ]BOQE@,FW..M%7XQ
M^\3_ 'A_.BDS:FI6W(+NQNW^*VEWRV\IM(])GB>8+\BN9$(4GU(%<9X ;5]*
MDL-/O(O%\06>4-;FPB^Q*&=B,N1OV\@YSU]J[J7Q7*NH11Q6#RVLFI&P$J'D
M;4)=SST# C_@+'TIW_"=:0+62Z=;M(!";B*1H#B>,,%+1CJ1EAV!P0<5B>D<
MAX0\$:O)H>D7.M:E<>3I[S7%KI1M%C,4I+@%GSN;AB<<=16;X%O=9\/Z58V]
MU8^-)7M;9\V+6$0MBP#$*'QO^F3UKT5_&%E'MC:TOQ=&X6W^R^1^]W,A=3C.
M,%5)SGL<XJ.?QI9+%*T-O=2?)-]G<Q8CN'C!+(C9Z_*W7&=IQG%,#A=$UW5;
M*+5-=N_"?B&[\4W43;?,LBL$2 _)"ASG:,Y)QECFJ\)U6;P=JNGV6AZ]_P )
M)K.Q;W4+ZS,2,78*V""=J(I.!V S7H]CXLM+G23>3Q3PO%' TT97)4R@;0.>
M>HJ(^-K#[2+>.RU*5VDEBC*6V1*\1(=5.>V"<G ..* N87@;2]?\.>)M4T_4
M[2U%G>0QW,,FGJ_V>.1 (V7YN0Q4*??%>ABL*+Q;I<UG-=QO*T,*0.S"/J)?
MN8_/GTJM_P )M8&Y-O%9:E*YFE@0QVV1))&3O53GM@G)P..N>* .GHKG)/&F
MF);0W8CNWLY(XY&N5@/EQ"0X7<3WSU SCO46B^+TO[EK6[MI;>4WMQ:12>6?
M*D:-F&T,3]XJN?3@XH ZBBN9U?Q='HNL36UU:3FTAL3=O/&NX_?"[0,^]0P>
M-5_M6^MKRPNK>&WDA3S3%Q'Y@X\PYP.>.,XXS0!UE%<V?&^CA@I>8-]D:\P8
MC]Q6VD?[V<\>U:&FZJUY?7UG+%Y<UJZGV:-QE6_F#[B@#4HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** *NHWJ:=IUQ>2*S)"A<JO4@52FU^""]TR
MV>*0&_5F1C@! J;CN_"IM=LI-1T*^LX0IDFA9%#' R1WKC[[X>PF73SIMM!:
M%;>6*XE5CG+1%1@=^: .K7Q-HC6LMRNJV9@B8+))YHPI/3/U[>M0CQ9I"PO-
M/>00Q!RJNT@(8  YXZ=>AYKG)/#.KZA=6]S<VMI;&W2" 1)+O$BHZL6)P,#Y
M>!UYIUYHFNB:YMDLTGTZZOGN;A4NA&\B;5"IR.A(Y]OK0!U0\0Z0US#;#4K4
MS3*'C3S!E@1D$?7MZTZSU[2M0NFMK34+:>=028XY 2 #@_K7,3Z!JTS7-HEG
M;1VUY<1W+3^=\\&T#*;0.2-O!!QS5[3- NK.?1G=(5%KY_F[6_OEB,>O6@!^
MI>*;^PUN'3$\.W=PUP6\B5+F%5D"C)/+9&!ZU:TOQ7IFISR6PGCANXY'C:WD
MD7?E>O2EU'3+FY\3:/?QA/(M?-\S+8/S(0,#OS6!=>$;^XM(X%,49_M&:X9U
M;D(ZD _6@#I1XFT5H)YQJMF8H"!*_FC"$G S^-*GB71I+F*V34[4SRC*1^8,
MMGI7#P>"-4-HL<L7[V&.*!6FOVF#JKJ3M7: H^7H>:OZMX?UV\UJ2;Y3:+=I
M<+MN0B;%QG,87+/QU+8Z4 =7;^(=(NY)8[?4[21XE+2!90=H'4GZ4ZUU[2[V
M-9+74+:96D$8*2 Y8]!]:X.U\/:IX@\/P0?9[:RBACG$4R2G=*69L#&W*CUZ
MU<M?#6KP$7_V7==1SPN(I]1,K2*F<C<5 7KQQ]:0'17GB[2K2]6S$Z23LCN
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M!_9&4444""BBB@ HHHH ?#_KX_\ >'\Z23_6O_O'^=+#_KX_]X?SI)/]:_\
MO'^= ^@VBBB@04444 %%%% #H_\ 6)_O#^=%$?\ K$_WA_.BDS6GL=311169
MWA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6)XOY\'ZP/
M^G23_P!!-;=(RAE((!!Z@T >:0/8P&^?4[6PN+PVEO\ 8X]2E6*-X/+&0KLI
M ^;=G STS4&F6'_"0:K:RVVG:5%&NFH%AU"W:\"*)6 V,2IQQP?3%>G26\4H
M DC1PO0,H.*>$7=NP,XQG% &*ZW-TESI<VG36EDD.U+J"=4#\#A54[E%<A;V
M+S6'A&VMDM<JUP$%U$94 "OU&0?QS7I6.*:(D&,*!CIQTH Y/P+&L,.J1RJD
M.H"\/VNVA39%$V!M,:_W64 Y[G-=?3!&H8L  QZD#K3Z "BBB@#&\50"X\,:
ME$=^&@;[C$'I[<UQ40N[6WOY#>:DEK!-;0L5E<^3 44N5'KUR>HKT#5M2BTC
M2[F_F5VC@0NRH,DX]*IQ>*-(EF@A-VJ32JA",K#:6&55CC"D]@<$T@.0@DN=
M1O1!;ZCJ3:5OG-O*LSJTBB,$?/\ >90W0_SK3\(R7HN[9;B[O)Q/IRS2_:'+
M?O-P&1GH<'H*W]2UB2TOK>PM+4W=[.K.$,@140=69L' Y X!ZU&OB!+>V9]6
MMI-/E$OE!#F3S#C.4*C+#'MQ@T <1>V.HG1]6F>;=I/]IO\ :[5+8>:8LKN9
M']>_3Z5,=4OS>,+6\O'UC[;B&TRWE&UP,';]W;CG=USWKL)/%N@Q,BOJ47SQ
MB4%0S (3@,2!@#/'-)+XOT*"Y>WDU%!*CF,J$<_/C.T8&"<=AS3 XH2+J=A9
MP_VAJTEZTL)O@S-MAD\P9ZCY&Z@!>,?G3M3OM2LI3;/?31Z;%=S)YUQ<3+CY
M5**9$!8C).,]>E=K)XKT2.**5K]/+E3>K!&.%SC+8'RC/'.*CL_%FFW6I3Z>
M\HBN(Y_(0-DASM!&&QC)SP,YH E\.WS3:7:P75V)[Y8%>0[&1BI)PQ# $9]Q
M7(F:X@CBN-0U'48K":_F2ZF$SC8HSL7(^XN<<C'UKLK[6=)TJ[ N[B.*XD7)
M^4L=H/5B <#/<X%(GB72'U#["E\AN/,\K:%;&_&0N[&,X[9H XJ*_P!=B2R0
M3W<B:H6M;=WR&0!\K(>XRF>>_%59M7NY=;,,,UUM,L\,\4L\DC;0AQN3:$09
MQCG)KM-2U'0;#7HIK^]9;V*(E(RSLJ*3@OM ('IN-6Y/$>E1W;6IO%,X_A4,
M1G&0N[&,D=LYH \]M&N;'4(Q9O<+=3-:$Q[FPR^6>QXQG%-LM2UB:SN&;6GA
MD%L3>!5N)FCDW=6^4>7Z87MR/6O2=#U>'7=*BU"!)$CDSA7!!&"1W^E:./>@
M#F_!-Y->:3,92[A)V5)#.TR.,#E'8!BOU_,UTM)BEH J:G8C4M-N+)G*"9"A
M8#)&:I2: DDT$AG8>3:-:@;1R" ,_I6Q12 XN'PL_P#PD-IA9EL[*S\EI7V@
M3OT4@ Y^49]*N+X2DM[6SCL=3DMYK>%K=I#"KB1&.3P>A]#748HI@<JG@M+;
MRY+&_E@GB*&*0QA\8!!R.^<GTJROA2&3PQ-HM[=27*S%F>9D4'<3G..G![5T
M-% '"WWA"2VT.XL[8>=<W<B!9+6VBMU@Q_&0,>_K]*N7?@6UN+J*>&6&,K$D
M3^99QS$A>A4L/E/Y_2NNHH Q=4T)[V2UGM+U[.ZME9$E$8<%2,$%367'X',-
MJ8TU1V<PI$[2VZ.L@!).Y#P0<].*ZZB@#B/^%<VB10"&XA$D:-&QELHY5VDY
M^16X3';'%2R> (7U(78OL8F252;6,R@J,;?,ZA?88KLJ* .)G^'5K>2W,MY=
MB2250 R6J)DAMP:0#B0CIR.E;NA:!'HUO+&7AD>5]Y\JU2%![!5'\R:V:*
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M"$/(X8_D:[S%)B@#+\.V%SIFCQ65T8F>)F :)B0REB0>0,'GI6K110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MS=Y_Q^2_[U=)7-WG_'Y+_O54=SFQ/PH@HHHJSD"BBB@ HHHH *EN?]>U15+<
M_P"O:@?0BHHHH$%%%% !1110 HZBI+G_ (^9/K48ZBI+G_CYD^M'4?0BHHHH
M$%%%% !1110 J_>'U%.F_P!?)_O&FK]]?J*=-_KY/]XT=1_9&4444""BBB@
MHHHH ='_ *Q?J*67_72?[QI(_P#6+]12R_ZZ3_>- _LC****!!1110 4444
M/A_U\?\ O#^=))_K7_WC_.EA_P!?'_O#^=))_K7_ -X_SH'T&T444""BBB@
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M4F: %HHS1F@ HI,TN: "BBB@ HHS1F@ HHS29H 6BBB@ HI,TN: "BDS2YH
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MT7#E13_L]<Y^T77_ '^- L%!!^T7)^LQ]O\ #]3ZU<HIW#E14^PJ!C[1<_\
M?TT&Q!_Y>+G_ +^GW_Q_E5NBB[#E14-@IS_I%R,^DQ]_\?Y5)#;B'.))7S_S
MT<M4]%*XU%(****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!!-;"9@3+*F!CY'*U%]A4?\O%S_ -_C65XF
MNK^*;2[6PO?LC75SY;RB)9"!@G@-Q6,_B+4],OI=+NIA=SQ3((YD18_,5U)
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M=C-_L.TQUF_[^FD.AVA&-TX^DI]_\?Y5IT478>RAV,W^Q+7.0TX.<C$S>_\
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M)V:-96SEPI. >3],UMT4  &**** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M$S1FN4:V&X_O[OK_ ,_4G_Q5)]F'_/>[_P# N7_XJKY3F]N^QUF:,UR?V8?\
M][O_ ,"Y?_BJ/LP_Y[W?_@7+_P#%4<H_;OL=9FC-<G]F'_/>[_\  N7_ .*H
M^S#_ )[W?_@7+_\ %4<H>W?8ZS-&:Y/[,/\ GO=_^!<O_P 51]F'_/>[_P#
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M9FC-<G]F'_/>[_\  N7_ .*H^S#_ )[W?_@7+_\ %4<H>W?8ZS-&:Y/[,/\
MGO=_^!<O_P 51]F'_/>[_P# N7_XJCE#V[['69HS7)_9A_SWN_\ P+E_^*H^
MS#_GO=_^!<O_ ,51RA[=]CK,T9KD_LP_Y[W?_@7+_P#%4?9A_P ][O\ \"Y?
M_BJ.4/;OL=9FC-<G]F'_ #WN_P#P+E_^*H^S#_GO=_\ @7+_ /%4<H>W?8ZR
MN<O/^/R7_>JM]F'_ #WN_P#P+E_^*J-M-MV)9FN23W-S)_\ %4U&QC5J.:M8
MFHJ#^R[;UN/_  )D_P#BJ/[+MO6X_P# F3_XJJT,+2)Z*@_LNV];C_P)D_\
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>;OL=9FBN5CMP)D/GW?WAUNI#_P"S44N4<:U^A__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tmb-20210505xex99d1018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !& )L# 2(  A$! Q$!_\0
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M[< D8/ ^M+#HUFCK)(KW$H.1).V]A]":** - *%Z #Z4M%% !BBBB@ HHHH
2**** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tmb-20210505xex99d1008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !% (0# 2(  A$! Q$!_\0
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I*&W6+YLEY#U=NIHHH8$]%%%( HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tmb-20210505xex99d1006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '7 Z@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V&3QGX:AU
M8Z5+KE@E^)/*-NTX#A_[N/6MVO*;?P;JOB'5?%%K<WHLM'FUH3/"UCF6<*(V
M#)*6& 2H&0#T/-/>/Q&-+UF]\[6BQU]HI%C9S)'IX<9,*?3NHSC.* /4\U6L
M-0M-3M5NK&XCN+=BP62)MRD@D'GV((KS%+CQ"#9O=/KO_"-G4Y]CQI)]K,'E
MCR=^!YFSS-V,\XV[N*RM"?Q!H>@Z:AM=92*72M1B6&.W=F%T9BT990/E;;DA
MC@>] 'ME-CE23=L=6VG:VTYP?0^]>6Z?/KAO;$:O)XC5VLM/-C]BC9E9]H\_
MS<C;G=][S,8'3FMWX<6+Z9#KUI-#>13C5KB0B?>59&<E&0MP<CJ1^- '<444
M4 %%%% !1110 4444 %%%% !1110 4444 %9^K:UIFA6HNM5OH+.W+!!).X5
M<GH,UH52U=#)H]XBH78PN H&23@T 0:/XBT?Q DKZ1J5M>I$0)#;R!PI/3./
MI6G7D%Z==LO ?A.RL[?58'-D1,;9) 4D$?R*ZH-^2>F2!D<U/9_\)7>QW]V)
MM3%Y%H5N]M'(S1QFZ*,')4X4MGL>] 'K%,:6-&56=5+G"@G!)]!7BK:EXA:3
M4[;1KG77D33+65H[WS?-4F3$S("-V<9Y ]=O:KMG::M/>^&]1U8:G-;P:I,(
MW5+@-'$T>$W _.5W<;F&<'GB@#V&BD7I2T %%%% &+JOBWP_H=VMIJFLV5G<
M.H98YY@A(/&>>U:T4L<\*2Q.LD;@,KH<A@>A!]*\[\0:@ND?$&]GNM)U*]MK
MK24@3[+9/.K/O8[20,#\:Y1++QOHNGZ3IT?VRVC6SS;) LKB.9I2=K>6"I(4
M@8<A<9H ]RJO>W]KIUJ]S>W$<$"8W22-A1DX'->>B+Q=_P )7-I:R79LX"VH
M)<LYV2%DP(,^@DR<>E<LL?BZ_P##FJ17XU"<?9HA-!)#,3]H\T$[2X],Y"97
M&*0'N8((HS7EK3^)AXA*;M6%\-2Y7:WV,6..N?N9Z_[6:RM"U'Q->VEM-I%Q
MK-S=M!>?:6NMQ@."PBV%OEW;@ ,<]<TP/9\BJD6J6,XNC%=1.+5BD^UL^60,
MD-Z<5Y+8S^,&T&XD>75C;"6U%R%CG^T*,_OC&7 8G'4*,#^&M_PA:SKI'BP^
M1?A+BZD:W-Y&XED0Q@ _,,G\>: ._L[RVO[6*ZM)DG@E7=')&<JP]0:L5XGH
M%GXC;1+:RTV76[/R=*8W7VH/&L<ZG,83<!UY!"\8ZUW?P^O[_7-+N=?O7F5;
M^7,%N[96&-1MX'NVX_E0!V-%%% !1110 53U/5+#1[)[S4KN&UMD(#2S-M49
MZ<U<KCOB7'-)X0<PVT]PR7,+F.",R.0'!.%')H UK;Q=X>O-/EO[;6K&:UB8
M+)*DP*H3T!],UL@@@$=#7C^KRZIJFH:QXAT'3=4L86M8;<%K9H99Y/-!)"8R
M0%R,X[U+#<>,(_%]W';MJ5PC"?:)4DC2/Y?DR&!B(ST*$'U% 'KF:*\7L;SQ
MC'H5]),VK2 I D@V7 DCE+?O&!9=Q&,Y$8QTP:BGN/%Q\-6S?:=966.ZN$VM
M!< NO'EY9,R#VW C^]0![=FJLNH6D-]#927$:7,X8Q1%OF<#K@=\5Y5=W/C>
M37K('[?;%X;8PJ4D=<_\M=^P>7GUWX]JW/'4&HGQ#I]U80W)>*PN\2P(QV.4
M^7D=#GI0!Z#FL]]>TJ.Y:V?4+=9UE6!HRXR)&&57'J?2O,9?^$MM+>>*TGUF
M5)-,MIIBY9W5RP\WRR1P^W/RC\JBLH]8AU.]GTJ+6%AGU>W*/=1R!Y(MAY;<
M,E<^M =#V3-,DECCQO=5W' R<9/I7E4%[KL.AWT@7Q/-K2P.+J(H1"K[^#&2
M#R!T\L'CWK+MX=8O%LYM3769K:RUE'1C'<!UA9/O 'YR,]SR/:@#V.RO[348
M3-9W$<\09D+1MD;@<$?@:LUY EQXC%M =0?7ULRUWM-HDGF&7?\ N@VT;MN.
MG;UI;T>,'@O9KF?5H[RWTN"2..V9@C3[OFX7ACCJ* /7LTM>4VMSXI3X@VP8
MZG/:RRJ949)(TCC*#.<@Q,N?0A\UZJ* %HHHH **** "BBB@ I"0!FEIC\H?
MH: ,D>*]!-C<WW]KV?V6V?RYYO-&V-O1CV-:D$\5S D\+K)%(H9'4Y# ]"*^
M=+CPOKS6UY8QZ;=_8[]KBZG'DM]^-CL'3J<\>M=C$WB6 00*-9COE2U&GQ0H
M_P!F\O:/,\SC;GKG=SZ4 >NE@H))P!WI@FB:'S0ZF/&[>#QCUS7D<:>*+CQ%
MJ=C,=4NK6:*X5MRRQ! 5^3@YC(SP"C ^HK6@DO;'X.0VFG6=\VHO"+58I8Y-
MZ2,<$G<,A1Z]*0'>Z;J^G:Q;M<:;>P7<*N4+PN& 8=1QWJ2&_M)KR>TBN(WN
M( #+$K99 >F1VKQ_3M-\7>%K;5],@TU+9[JU2:!M.9I5#)A7PQ48<C)QZU+;
M0ZS#/KNKZ-'K3-!]GGA6\219+I5'SI\PRP]J8'LF:.*\:UR7Q?!HUAAM9^UW
M$$MTQ@\UMDA.5CP@Z@=F(7V-6;U_$\DNH7L<^LK) ;-K=$WA&R!YGRXPW?/I
M0!ZYF@UYA#/XA-Y?AFUW^W \WE1K&?L1CQ^[R3\@]L?-GK6/8S^-3H]W(TVJ
M&$& 7"B.;SEY_>F,R#)..R#'I0!Z[#J-E.URL5S$[6K;9PK9\LXSAO3BL[3?
M&'AS6+TV>G:W875R,_NHIP6XZ\5S/@RVF6W\4OY.H"*>X9K=KV-EED7R^#\P
MR?QYKE].%[J^E>&=+T_1=1AU/2YC++<W-FT,<8&[@.V-V21P*$![3FC->/:)
M'XUOUU".>[U""=+9FD#K,,3ALJ%9\+R!C"97!I;NX\9W&@P:M(-0@6\NRUQ;
M+YN^WC"X4 1@N 6Y.!Z9H ]7_M"U^W_8?M$?VK9YGD[OFVYQG'I5D&O'98/%
MJO%=K'>R:E_9"J\ZPD28\WD#/\>WMUI+_4M8MK,NEUKT>DR:E;QV[R[UN64@
M^8!N^<KGU_"@#V/-&:\@5?$EW+:Q"?7DT\O=M"[-(DIC"YC\P]>O3/-0QR>-
M8--E%K-J\UQ-I4<KF?>Q$N_#;>/E;;V'- 'LN::TJ*ZH74.W12>3^%>3Z<OB
M>[BTN*>ZU5;.;4F4M'YT;B'9T9G ?;GH6Q2:!;:F_B30+_64U9S&+FV$SB4X
MP_R;\=B.YX- 'H&I>+_#NCWPLM2UJQM+H@$133!6P>G!K1M]2L[N>6"WN8I9
M80ID5&!*Y&1GZBO/]7\-ZQKGC;78+6]2PL+FSABEDEL?.\T8.0C%@ 1^-9-U
MHFJ:-J6JR:4^JH;:6RB@,6[;*@ #$@##<=?2D@9[!FC->0PWWBJ;Q;-C^VH(
MG^TQLIBD=5P/W97($?TV_B:I65UXW&A:FD7]IR['A)G83@E<_O JN/,!QUV$
MC^[3 ]LHKEO ;:JV@,VJ232$S.8#,CJXCSP#YGS'ZL,UU- !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !28I:* #%
M%%% !BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HKBVAN
M[:2WN(UEAD4HZ.,A@>H-2T4 9.C^'-(T'S/[,L8[<R@!V!)8@=!DDG [#H*U
ML444 %%%% !1110 4F*6B@ HHHH :RAE((R#P:KZ?I]II=FEG90+!;H25C7H
M,DD_J35JB@ HHHH K7]A;:E92V=W'YL$HVNA8C(_#FGVMK!8VL5K:PI#!$H2
M.-!A5 Z "IJ* "BBB@ HHHH **** #%)2T4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%(>E "T5S]OXRT:XNEMUDN5WRF%)9+25(F
M<'&T2%=I/XUN^:@ZNO7'7O0 ^BH+N[@L;62YN95BAC&7=N@%9<?BK27$FZ>6
M)HPK%)H'C8J3@,%8 D9[B@#;HJ"&ZCFCW@E1G;\X*G/T-$=U'(91\R^6VPEU
M*C/L3UH GHICR(IP6 .,XSSBH;&^@U&U2ZMGWPOG:V",X..] %FBBB@ I*6J
M-_JUCILENEY<QQ/<2"*%6/+L>P% %W%&*444 &*J7NFV>HB$7<"RB&02Q[OX
M7'0U;HH 04M%% !15:_O[73;.2[O)XX+>)=SR2'  JK<:]IUK9PW<UP%@F3?
M&^TG(QG/ZB@#3HJAIFKVFK)(UJ[[HVVNDL31NIZ\JP!J_0 48HHH **** "B
MD) &3658>(M,U*[-M;3.TF"REHF59 #@E&(PP'M0!K4444 %%%% !1110 45
M#=7,-G;27%Q(L<,2EG=CP *JZ9K-EJRR&UD<M&0'22-HV7(R#M8 X(Y!H T*
M*** "BBD- "T50@UFPN-5N=,BN%:\ME5I8\'Y0W3GI5T.ASAAQUYH =13?-3
M:&WK@]\T>8F2-PR.O/2@!U%-9U7.6 QUR:@O;ZWT^V:XN9 D2XR>O4@=/J10
M!9HI%8,H(Z'FEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P />)8];BA1[6YM;E[=)]LT6P.I RR<G(R>^#THN'LUW?WEC[/KW_01L?\
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MR-$\3(N[!0C/-3W'B33;74#9222[U(5W6%VCC)Z!G P":+A[-=W]XOV?7O\
MH(V/_@(W_P 71]GU[_H(V/\ X"-_\753_A,]'6.:21[F(1*'Q):R*74G 901
MEADCI4G_  EVE?9O-!N2XD,1MQ:R><& R04QGISGTHN'LUW?WD_V?7O^@C8_
M^ C?_%T?9]>_Z"-C_P" C?\ Q=0CQ;H[31QK/(ROMS*(7\M"WW59L84GT-7-
M*UFUUB.26T$QCC<IODA9 Q!(.W(YY':BX>S7=_>0_9]>_P"@C8_^ C?_ !='
MV?7O^@C8_P#@(W_Q=:]%%P]FN[^\R/L^O?\ 01L?_ 1O_BZ/L^O?]!&Q_P#
M1O\ XNM>BBX>S7=_>9'V?7O^@C8_^ C?_%T?9]>_Z"-C_P" C?\ Q=:]%%P]
MFN[^\R/L^O?]!&Q_\!&_^+H^SZ]_T$;'_P !&_\ BZUZ*+A[-=W]YD?9]>_Z
M"-C_ . C?_%T?9]>_P"@C8_^ C?_ !=:]%%P]FN[^\R/L^O?]!&Q_P# 1O\
MXNFM!KRH6_M&QX&?^/1O_BZV:9+_ *IOH:+B=-6W?WG+?VAKO_/W9?\ @,W_
M ,52_P!H:[_S]V/_ (#-_P#%445IH</-/^9A_:&N_P#/W8_^ S?_ !5']H:[
M_P _=C_X#-_\5111H'-/^9A_:&N_\_=C_P" S?\ Q5']H:[_ ,_=C_X#-_\
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MH_M#7?\ G[L?_ 9O_BJ**-!\T_YF']H:[_S]V/\ X#-_\51_:&N_\_=C_P"
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MXY(8T4>6#@JJL9.".=W7T%-N/%.L6FH264.L1ZA$XM1]H2.%3#YA;)S]WG
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M^9/_ ,^X_P"_@H\R?_G@/^_@HL',B:I6_P"/9/\ >-4_,G_Y]Q_W\%2M+/\
M9T_T<?>/_+04K#4AU%0^9/\ \^X_[^"CS)_^??\ \B"G87,B:BH?,G_Y]Q_W
M\%6;>UO;B/>D" 9QS(/\*0X^]HAE%6/[-O\ _GA'_P!_?_K4?V;?_P#/"/\
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M-C.<=ZH:1X2L-+CNEDQ=M= +*988U5E&<#8JA>Y)..2:Z"B@"JFGV<:(D=K
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M\ANHI+J2[$13$_VCSXV)'.UBJL/=3TH&==1110 4444 %%%% !1110 4444
M%%%% !3)?]4_^Z:?3)?]4W^Z:!/8Y>BBBM3S HHHH$%%%% PJ6#[[?[IJ*I8
M/OM_NF@<=R*BBB@04444""BBB@85-'_Q[R_A4-31_P#'O+]10..Y#11102%%
M%% PHHHH *D;_CV3_>-1U(W_ ![)_O&@:(Z***"0K<TG_CS_ .!&L.MS2?\
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M_H*Q?^ @_P#BJ+!SOL_P-6BLK['K'_05B_\  0?_ !5'V/6/^@K%_P" @_\
MBJ+!SO\ E?X&K165]CU?_H+1?^ @_P#BJ/L>L?\ 05B_\!!_\518.=_RO\#5
MHK*^QZO_ -!6+_P$'_Q5'V/6/^@K%_X"#_XJBP<[_E?X&K165]CUC_H*Q?\
M@(/_ (JC['J__05B_P# 0?\ Q5%O,.=]G^!JT5E?8]8_Z"T7_@(/_BJ/L>L?
M]!6+_P !!_\ %46\PYWV9JT5E?8]8_Z"L7_@(/\ XJC['K'_ $%8O_ 0?_%4
M6#G?9_@:M%97V/6/^@K%_P" @_\ BJ/L>L?]!:+_ ,!!_P#%46\PYW_*_P #
M5HK*^QZQ_P!!:+_P$'_Q5'V/6/\ H+1?^ @_^*HL'.^S-6BLK['K'_05B_\
M 0?_ !5'V/6/^@M%_P" @_\ BJ+>8<[_ )6:M%97V/6/^@M%_P" @_\ BJ/L
M>L?]!:+_ ,!!_P#%46\PYWV?X&K165]CU?\ Z"L7_@(/_BJ/L>L?]!6+_P !
M!_\ %46#G?\ *_P-6BLK['K'_05B_P# 0?\ Q5'V/6/^@K%_X"#_ .*HL'.^
MS_ U:*ROL>L?]!6+_P !!_\ %4?8]8_Z"L7_ ("#_P"*HL'.^S_ U:2LO['K
M'_05B_\  0?_ !5'V/6/^@K%_P" @_\ BJ+!SOL_P-3%)@5F?8]8_P"@M%_X
M"#_XJC['K'_05B_\!!_\51;S#G?\K_ U,48%9?V/6/\ H*Q?^ @_^*H^QZQ_
MT%8O_ 0?_%46#G?\K_ U,48K+^QZQ_T%8O\ P$'_ ,51]CUC_H*Q?^ @_P#B
MJ+!SO^5_@:F* ,5E_8]8_P"@K%_X"#_XJC['K'_05B_\!!_\51;S#G?\K_ U
M:*ROL>L?]!:+_P !!_\ %4?8]8_Z"L7_ ("#_P"*HL'.^S_ U:*ROL>L?]!6
M+_P$'_Q5'V/6/^@K%_X"#_XJBWF'._Y7^!JT5E?8]7_Z"T7_ ("#_P"*H^QZ
MO_T%8O\ P$'_ ,518.=_RLU:*ROL>L?]!6+_ ,!!_P#%4?8]7_Z"L7_@(/\
MXJBP<[[/\#5HK*^QZO\ ]!6+_P !!_\ %4?8]8_Z"L7_ ("#_P"*HL'._P"5
M_@:M%97V/6/^@K%_X"#_ .*H^QZQ_P!!6+_P$'_Q5%@YWV?X&K3)?]4W^Z:S
M?L>L?]!6+_P$'_Q5-DL]7\MLZK$1@_\ +H/_ (JBPG-VV?X&715/[/?_ /00
M3_P&'_Q5)]GO_P#H()_X##_XJM;'F<[[%VBJ7V>__P"@@G_@,/\ XJC[/?\
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M^VZO_P!!"'_P%'_Q5'VW5_\ H(0_^ H_^*HY&'UJ/9G545ROVW5_^@A%_P"
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M8>27'ER*,A3D_.#ZC'3I44&M>(+:XM(+Z#3[IKZ!GMC;!XL2!-^Q@Q;@C/S
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M_P"/2+_=%<W726?_ !Z1?[HJ9'3AMV3T445!UA11FC- !1110 4444 %%%%
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MU3T4!;S*^^Z_YX1_]_?_ *U&^Z_YX1_]_?\ ZU6** MYE??=?\\(_P#O[_\
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M*]' Q2T 5-,@DMM*LX)0!)' B/@YY"@'FK=%% !1110 4444 %%%% !1110
M5@>+]&DUW0_L$<2R!IXF=6?;E P+<_2M^H9IO) /ER/G^XN: O8X#4?A^T5Y
M=G1K=8()(8B%-PV9'20-MRV[&0.O2IK+PK?'48;Z>SV;C.\B37(F96:/:IZ
M GVKL_MO_3M<_P#?NC[;T_T:YY_Z9T6)YD<4_AG5K6SM?L=I;[XK2*)T4QYR
MK@G;N!4''0D57_X1+6Y+=D>) \\MQN9K@,8UD0 ,3@9Y'('ZUWOV[_IVN?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH8]!QDT:"]XB^WVG_/S'_P!]?Y]:3^T+3_GYC_[ZJ?"^U&%]!0'O$']H6?\
MS\Q?]]4?VA9CK<Q_]]5/M7T'Y4W=&&*EDR!DC(Z>M/0/>(CJ%GT^TQ?]]5'#
M<Z=;ILBEAC3).U3@9)YJT-A (VD'G--:2%'5&= [_=4D9/TI:![Q'_:%G_S\
MQ?\ ?5']HV>?^/F+_OJI\+Z"@A0,G HT#WB#^T;/_GYB_P"^JBENM.G"^;-
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M_%2X'I4L &]N/X32'&]RK]LMO^>\?YT?:[;_ )[I^=2X'I1@>E,6I%]KM_\
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MH'O%?^T;/./M,7_?5']HV?\ S\Q?]]5/L'H/RI=@]!^5&@>\5_[2LSTN8O\
MOK_/K1_:5E_S]1?]]58V#T'Y4;!_='Y4:![Q7_M*R_Y^HO\ OJD_M*R_Y^HO
M^^JL[!Z#\J-@]!^5 >\5CJ5D.MU%_P!]?Y]*7^TK+_GZB_[ZJ?8/[H_*EV#T
M'Y4] ]XK?VG9?\_47_?5']I61_Y>HO\ OK_/J*L[!Z#\J0H/[H_*C0/>*_\
M:=D?^7J+G_:_SZBC^T[+_GZB_P"^JL[!Z#\J-H]!^5&@>\5O[3L@,_:HO^^J
M/[2LO^?J+_OK_/H:L[!Z#\J38/0?E1H'O$"ZC9LX07,18G  ;O5JF[1Z#\J<
M.E(:OU"BBB@844FX>HHW#U% KH6BDW#U%&X>H_.@+H6BDW#U'YT;AZC\Z NA
M:*3</4?G1N'J/SH"Z%HI-P]1^=&X>H_.@+H6BDW#U'YT;AZC\Z NA:*3</44
M;AZC\Z NA:*3</4?G1N'J/SH"Z%HI-P]1^=&X>H_.@+H6BDW#U'YT;AZC\Z
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M=9NX[V"ZN[PS):K<B&>%UN'"^7GE@JJQ!]./6O4RJ$Y(4GIDT".-0 %4 =
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M[QII(6L,(1'$!P^,;@<8;<3@YJ5KW6-/CTZW_M2YN9=7MT$4LP4^7+P6(P
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MG1N'J/SH"Z%HI-P]1^=&X>H_.@+H6BDW#U%&X>H_.@+H6BDW#U'YT;AZC\Z
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MY( [27"*H*QHN?\ 6+GYNO;@9I<S#V<.R.S_ .$9T7_GPB_7_&C_ (1G1?\
MGPB_7_&O,_A[XU\S4?%%Y?SW^H3R/;S>3:V<TAB#+@HB8SA20,XYQFN@F:]'
MQ(AFEU&ZDMKK1[B6&U=/+6  QX&WKNY.2>>W%.[#V4.R.L_X1G1?^@?%^O\
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M?LX=D9'_  C&C?\ 0/B_7_&C_A&-&_Z!\7Z_XUKT478>SAV1D?\ ",Z+_P!
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MK_C1_P (QHW_ $#XOU_QK7HHNP]G#LC(_P"$8T;_ *!\7Z_XT?\ ",:-_P!
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MZ9/'H* .@TC5-*LK>#1]/ANFMK2)K>&1;=C&YB&&57Z%A@_4@XK7TV/3WTJ
M6$,*6,D>8XXXPJ;6Y^[VZGCZUQVA>']0T?5;?=!)!':S7$ES?-<AH[F%BQ1
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M553A0 /0"@8ZBBB@ HHHH **** "BBB@ HHHH **** "F2_ZIO\ =-/IDO\
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MUPH) ]ZN6]S#=V\=Q;RK+#(-R.AR"/K1=!RS[_A_P2A_;]G_ ,\[S_P#D_\
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ME_V_9_\ /.\_\ Y/_B:/[?L_^>=Y_P" <G_Q-:E%%T3RS[_A_P $R_[?L_\
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M[/\ YYWG_@')_P#$T?V_9_\ /.\_\ Y/_B:U,48HT#EGW_#_ ()E_P!OV?\
MSSO/_ .3_P")ILFO69C8>7>=#_RZ2?\ Q-:V*9+_ *I_]TT: XSMO^!Q?]JV
MW]VY_P# 9_\ "C^U;;^[<_\ @,_^%7>:.?4UKH>9:7<I?VK;?W;G_P !G_PH
M_M6V_NW/_@,_^%7<FCFC07++N4O[5MO[MS_X#/\ X4?VK;?W;G_P&?\ PJ[S
MZFCGU-&@<LNY2_M6V_NW/_@,_P#A4D.K6P9OEN?NG_EVD_PJSDU+ 3O;_=-#
ML5%2ON9G]JVW]VY_\!G_ ,*7^U;;^[<_^ S_ .%7>?6C)HT)M+N4O[5MO[MS
M_P" S_X4JZE YPD=TQ]!;2?X5<R:O:5_Q^?\!-#:*A"4I)7_  ,G[8O_ #[W
MG_@+)_A1]L7_ )][S_P%D_PKLJ,5'.=7U5_S?@<;]L7_ )][S_P%D_PIZWZ"
M&13!>9.,?Z+)_A77XHQ1S#6%:^U^!QGVQ?\ GWO/_ 63_"E^V+_S[WG_ ("R
M?X5V6*,4<_D+ZJ_YOP.-^V+_ ,^]Y_X"R?X5>TW58+<OYD-X,XQ_HDG^%=)B
MC%#E<J&'E%W4OP,O^W[/_GG>?^ <G_Q-']OV?_/.\_\  .3_ .)K4Q1BIT-N
M6??\#+_M^S_YYWG_ (!R?_$T?V_9_P#/.\_\ Y/_ (FM3%&*- Y9]_P,O^W[
M/_GG>?\ @')_\31_;]G_ ,\[S_P#D_\ B:U,48HT#EGW_#_@F7_;]G_SSO/_
M  #D_P#B:/[?L_\ GG>?^ <G_P 36IBC%&@<L^_X?\$R_P"W[/\ YYWG_@')
M_P#$T?V_9_\ /.\_\ Y/_B:U,48HT#EGW_#_ ()E_P!OV?\ SSO/_ .3_P")
MH_M^S_YYWG_@')_\36IBC%%T'+/O^!E_V_9_\\[S_P  Y/\ XFC^W[/_ )YW
MG_@')_\ $UJ8HQ1H'+/O^!E_V_9_\\[S_P  Y/\ XFC^W[/_ )YWG_@')_\
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M7B>?S[BWL;:.64WRZ=;^8Q56EV;Y&;_949Z<DJ1576?$FJ:)I5_//)I,KP-
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MCYEQ"%-U-;1;8HMQPN0S9_+-0ZEXRBMK"\GM;*ZD$ <),T)\J1D^\H(.?7L
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M9S^E/TOPS!I.OZEJ=O/)LO@N;8@;(F!8L5_WBV2/7)[U9W:[_P \M._[[?\
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M\M._[^/_ (4;M=_YY:=_W\?_  HL'M/)_<:M%96[7?\ GEIW_?Q_\*-VN_\
M/+3O^_C_ .%%@]IY/[C5HK*W:[_SRT[_ +^/_A1NUW_GEIW_ '\?_"BP>T\G
M]QJT5E;M=_YY:=_W\?\ PHW:[_SRT[_OX_\ A18/:>3^XU:*RMVN_P#/+3O^
M_C_X4;M=_P">6G?]_'_PHL'M/)_<:M%96[7?^>6G?]_'_P *-VN_\\M._P"_
MC_X46#VGD_N-6BLK=KO_ #RT[_OX_P#A1NUW_GEIW_?Q_P#"BP>T\G]QJT5E
M;M=_YY:=_P!_'_PHW:]_SRT[_OX_^%%@]IY/[C5HK+C;6_,7S([ )GYMKOG'
MMQ6F.E(<97%HHHH*.*O/B#;V>F^)+I[5/,T6Y-N(3. T^ IR/3[WOTKH#XCT
M==7&DMJ-N-0V[OL^_P"?IG&/7'..N.:XW4_A?:ZE:^)WFBTZ34=4NC/:7DEL
M&>V7"@#=C/\ ">GK4I^'=Q_PE\FJB^5K1]174O*>27*RA-H7:&V8R,[\;L<4
M =/#XP\/7$1EBU>T:,6[7+-OX6(-M+$]AN!'/<5C:U\0+:VL-.N="AM]7-[>
M&T4?:A J.$+G<S#@X'0^HK%@^'.MVMIKJ0ZQ9I/K:"6Y=+;;Y<XDW?N\<B,J
M=O/(/S#DU7F^%^IO8L@FTB:0ZN=2\F]BEN(6!A\LHX8[GYYR3S2 ZC1/'=K>
M:7?WFL0II+6%S]FFWW"RQEB 1L=>&/(X'.>*U)_%N@6VGVM])J]H+:[.VWD\
MT8D/<#Z=_3O7&Z?\.-1LHUNEO--AO8M234(+.UMFCLD*QF,J$R2NX')(Z$#B
MK5MX#U+3Y[/4;6_LWU!)KR2=9H6\D_:2"VP Y&TJ,9Z\YQF@#9T/QUI.J^'1
MJUQ<0V>RW2XN(GDSY*,2%)..0<<5-XL\27'A^RL9;+3O[0N+V[CM(H3,(@6<
M$@EB..E<*/ MU;ZMX4T=&FEBMK<1ZO,D#+!+%$_FQ+N/&=_&T<X)SQ72>(?
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M; F=@Z$[L9.>:U=#\.:C97-C)J%S;2)80/#"+=&!?<>K9Z8'&!]: .JHHHH
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M94E5W=P2?,(+'I[<4LOA"R>:.>.XNH;B)(EBF1ERGE@@$9&#D$YSQ719%'%
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M+V;:IJ"Z:;^^:W=8UCC5BIX/5\J?E'<'FB[#V<>QUO\ PCZ_]!35?_ HT?\
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M4?\ "/+_ -!35?\ P*-;-1S2>5"\F,[5)QZT<S#V<>QE?\(^O_05U7_P*/\
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MU\TL&HWD]M]EVJ$B5-^TJ<9S\G.3WHNP]G'L;W_"/K_T%-5_\"C1_P (^O\
MT%-5_P# H_X5E7]]<7>I:HDFJW.FV.FI&2;6)6=V8$Y.58X&.@'/-4&\?>3%
M!%;&'4BD/FS3A9(C*-Q7"($/S_*>#@9%%V'LX]CI/^$?7_H*:K_X%&C_ (1]
M?^@IJO\ X%'_  K'3QA>M<LYTR);$7+6JR&<^86V!@=FW@<X/.:JP^-=8DM%
MN7T6T6,VB7IQ>$D1$X(^Y][N.WO1S,/9Q['1?\(^O_04U7_P*/\ A1_PCZ_]
M!35?_ H_X5AWGC*=-2>R2*U"2;XXWBN"\J,$+ LH7:![;L^U7O#>N:C=BUM=
M5M8XIY;)+F.2.;?O& #N&T8;)!XR.:+L7LX]B]_PCZ_]!35?_ H_X4?\(\O_
M $%-5_\  H_X5)I-S+>3W\S2EX1/Y42X& %'/ZD_E6K1=C]G'L8W_"/+_P!!
M35?_  */^%'_  CR_P#04U7_ ,"C_A6S11=A[./8SK/219SB47U]-QC;-.67
M\JGO;+[;$(S<7$.#G=!)L/YU:HHN-125C&_X1Y?^@IJO_@4?\*/^$>7_ *"F
MJ_\ @4?\*V,TN:+L7LX]C&_X1Y?^@IJO_@4?\*/^$>7_ *"FJ_\ @4?\*V,B
MC-%V'LX]C'_X1Y?^@IJO_@4?\*/^$>7_ *"FJ_\ @4?\*V,TN11=A[./8QO^
M$>7_ *"FJ_\ @4?\*/\ A'E_Z"FJ_P#@4?\ "MC(HR*+L/9Q[&/_ ,(\O_04
MU7_P*/\ A1_PCR_]!35?_ H_X5LYI,BCF8>SCV,?_A'E_P"@IJO_ (%'_"C_
M (1Y?^@IJO\ X%'_  K8S2YHYF'LX]C&_P"$>7_H*:K_ .!1_P */^$>7_H*
M:K_X%'_"MC-&:+L/9Q[&/_PCR_\ 04U7_P "C_A1_P (\O\ T%-5_P# H_X5
ML9%+FCF8>SCV,;_A'E_Z"FJ_^!1_PH_X1Y?^@IJO_@4?\*V<T478>SCV,;_A
M'E_Z"FJ_^!1_PH_X1Y?^@IJO_@4?\*V:*+L/9Q[&-_PCR_\ 04U7_P "C_A3
M9- 41L?[4U0\'_EZ/^%;=,E_U3?[IHNQ.G&VQQ']EC_G^U#_ ,"3_A1_98_Y
M_M0_\"3_ (5?HK6[/,]G'L4/[+'_ #_:A_X$G_"C^RQ_S_:A_P"!)_PJ_11=
MB]G'L4/[+'_/]J'_ ($G_"C^RQ_S_:A_X$G_  J_11=A[./8H?V6/^?[4/\
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MJ&)].G;;$;61L9PFTG]*- _>=T1_VWI/_03M/^_Z_P"-']MZ3_T$K3_O\O\
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MS0?\\(_^^!1]F@_YX1_]\"C0+5.Z*O\ ;FE?]!*T_P"_R_XT?VYI7_02M/\
MO\O^-63;VX_Y8Q_]\"H5;3W1W4VQ5/O,-I"_7THT#]YW0S^W-*_Z"5I_W^7_
M !H_MS2O^@E:?]_E_P :DA-A<*6@^SRJ."4VL!^5.B2SF3?$D#KTW* 1^E&@
M?O.Z(?[<TK_H)6G_ '^7_&C^W-*_Z"5I_P!_E_QJ2<Z?;!3/]FBW=/,VKG\Z
MB-SI*OL::R# XP73.:- M4[H7^W-*_Z"5I_W^7_&C^W-*_Z"5I_W^7_&K'DV
MN\)Y46XC.-HSBG?9H/\ GC'_ -\"C0/WG=%7^W-)_P"@E:?]_E_QH_MS2O\
MH)6G_?Y?\:M?9H/^>$?_ 'P*/LMO_P \8_\ O@4:!:IW14_MO2?^@E:?]_E_
MQH_MK2O^@G:?]_U_QJ29M.MV59C;1LWW0Y52?IFGA+-I3$$@,@&2H R!]*-
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M(_\ O@4?9H/^>$?_ 'P*- M4[HJ_VYI/_02M/^_R_P"-']N:3_T$K3_O\O\
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M]\"C0+5.Z*O]N:3_ -!*T_[_ "_XT?VYI/\ T$K3_O\ +_C5K[-!_P \(_\
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M4QM"O=5!W;B,#!& >YK,L-+UR30;+09=)-M'%<^9-=R3QE=@E,@V!26)/ Y
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M_P"@=>_G%_\ %T44<J#ZQ4[A_P )&G_0.O?SB_\ BZ:_B%61E&G7F2,=8O\
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M\71_PD:?] Z]_.+_ .+HHHY4'UBIW#_A(T_Z!U[^<7_Q='_"1I_T#KW\XO\
MXNBBCE0?6*G</^$C3_H'7OYQ?_%T?\)&G_0.O?SB_P#BZ**.5!]8J=QT7B!9
B94C^P7:[CC)\O _\?K8!R***B229TT)RFGS"T445)T'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tmb-20210505xex99d1010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !% '<# 2(  A$! Q$!_\0
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M/<0.R[7,,FW>/?\ QZU9M[>.VB$<2X4?B3]3WJ:BE=@&**** "BBB@ HHHH
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&%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tmb-20210505xex99d1014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  U +8# 2(  A$! Q$!_\0
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=4;9FW)#=.$XZ D\4452V8NIT5%%%2,**** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tmb-20210505xex99d1002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210505xex99d1002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !: 2\# 2(  A$! Q$!_\0
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2IJ5;KE2LC;#87EE[6<N:1__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
